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Summary 
Col4a3 knock-out (Col4a3KO) mice, a genetic model of autosomal recessive Alport 
syndrome, are broadly used to study Alport disease and to test potential therapies. 
However, little is known about gender differences in the progression of renal disease in 
Col4a3KO mice although human autosomal form of Alport syndrome is shown to 
affect males and females equally. Furthermore, influx of macrophages is associated 
with disease progression in Alport kidney but their exact contribution remains elusive. 
In chapter 1, we investigated i) gender-phenotype correlations of Col4a3KO mice and 
ii) the role of macrophage in renal disease progression in Col4a3KO mice. We show 
that male and female Col4a3KO mice exhibit similar disease progression assessed by 
body weights, biomarkers of tubular injury, kidney function parameters and renal 
pathology. Those data demonstrate that Col4a3KO mice of both sexes can be used to 
study Alport disease and to evaluate experimental therapies. In addition, ~70% 
macrophage depletion in Col4a3KO kidney by clodronate liposome treatment did not 
improve renal pathology and kidney function. This result suggests that targeting 
macrophage alone is not sufficient to alleviate disease progression in Alport syndrome. 
Dipeptidyl peptidase 9 (DPP9) is a cytosolic serine protease of unknown physiological 
function and substrates. In vitro studies suggest the role of DPP9 in cell behavior and 
immune response but there is no in vivo data supporting those findings. Recently, 
neonatal lethality of DPP9 enzyme inactive mice is reported but the cause of their 
death is unknown. In chapter 2, we investigated the cause of neonatal lethality of 
DPP9 enzyme inactive mice (DPP9ki/ki mice) and characterized their immune related 
phenotype to better understand the physiological role of DPP9 enzyme. We show that 
DPP9ki/ki mice die within 24 hours after birth due to the suckling defect as proven by 
their rescue by manual feeding. Maternal behavior, energy homeostasis, and 
development of sensory-motor neuronal pathways which can influence suckling 
response are normal in DPP9ki/ki mice. Instead, DPP9ki/ki mice display microglossia 
with defects in the formation of intrinsic distal tongue muscle which derive from 
migratory muscle progenitors. On the other hand, intrinsic proximal and extrinsic 
tongue muscles deriving from head mesenchyme formed normally in DPP9ki/ki mice. In 
accordance with defects in intrinsic distal tongue muscle, reduced number and 
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impaired survival of migratory tongue muscle progenitors are observed in DPP9ki/ki 
mice. CXCR4 signaling, known to be important for survival and migration of muscle 
progenitors, is not impaired in the absence of DPP9 enzymatic activity, although we 
cannot rule out that DPP9 enzyme regulates the function of SDF1, ligand of CXCR4. 
In addition, we show that DPP9ki/ki mice have defect in fetal hematopoiesis but their 
hematopoietic cells are fully functional and can reconstitute myeloid and lymphoid 
lineages in lethally irradiated mice. In summary, we report for the first time that DPP9 
enzymatic activity controls survival of migratory tongue muscle progenitors. Absence 
of DPP9 activity results in impaired tongue development, suckling defect, and neonatal 
lethality in mice. However, DPP9 enzymatic activity in hematopoietic stem cells is not 
essential for normal hematopoiesis. 
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1 
Contribution of gender and macrophages in 
Col4a3 knock-out mice  
1.1 Introduction 
Alport syndrome is an inherited genetic disease which affects approximately 1 in 5000 
people and is caused by mutations in the type IV collagen genes (Hasstedt and Atkin 
1983). In particular, mutations in the type IV collagen α5 chain gene (COL4A5) are 
responsible for the X-linked form of the disease, which accounts for ~85% of the 
patients and mutations in the type IV collagen α3 or α4 chain gene (COL4A3 or 
COL4A4) lead to the autosomal form of the Alport syndrome (Hertz et al. 2012). Type 
IV collagen assembles primarily as α3α4α5 heterotrimers in the adult glomerular 
basement membrane (GBM) and is one of the main structural components essential for 
GBM integrity and function. Mutations in any of the three collagen chains can result in 
defective assembly of the GBM leading to the renal pathology of Alport syndrome 
manifested by irregular thickening and splitting of the GBM, podocyte effacement, 
glomerulosclerosis with extracellular matrix deposition, kidney fibrosis, and 
ultimately, end stage renal disease (ESRD) early in life (Figure 1.1; Flinter 1997; 
Kruegel et al. 2013).  
 
Figure 1.1  Electron microscopy images of renal tissue from patients with Alport 
syndrome. (A) Thickening and splitting of the GBM. Scale bar: 500 nm. (B) Irregular 
thickness of the GBM. Scale bar: 1 µm. (Gubler 2008) 
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Col4a3-deficient (Col4a3KO) mice are developed by gene targeting at the Col4A3 
locus and are raised on a 129/SvJ genetic background. In the absence of type IV 
collagen α3, α4, and α5 chains, mice develop progressive glomerulonephritis as well as 
ESRD and die at an age of approximately 10 weeks (Cosgrove et al. 1996; Gross et al. 
2003). The structural and functional manifestation of renal pathology of Col4a3KO 
mice closely resembles that of human Alport syndrome, making Col4a3KO mice an 
ideal model to understand Alport pathology. The translatability of Col4a3KO model 
for the autosomal recessive form of Alport syndrome is demonstrated by animal 
studies with Col4a3KO mice that have successfully assisted in identifying effective 
therapies for Alport patients. Well-established evidence comes from RAAS blockage 
with ACE inhibitors which delays progression to renal replacement therapies in 
humans with Alport syndrome (Gross et al. 2012; Temme et al. 2012) and is effective 
in delaying renal failure in Col4a3KO mice (Gross et al. 2003). While human 
autosomal form of Alport syndrome is shown to affect males and females equally 
(Mochizuki et al. 1994), relatively little is known about gender-specific susceptibility 
to disease progression in Col4a3KO mice. One of the goals of this study was to 
determine whether gender has a significant impact on the onset and progression of 
kidney disease in Col4a3KO mice. 
It is well established that interstitial inflammation is a prominent feature of progressive 
renal diseases including Alport syndrome. As early as 1961, Whalen and colleagues 
reported the presence of CD68-positive foam cells in human Alport syndrome (Whalen 
et al. 1961). Foam cells belong to the monocyte-macrophage lineage and acquire their 
‘foamy’ appearance owing to the accumulation of fat. Extensive macrophage 
infiltration is also reported for the Col4a3KO kidney with a strong correlation to the 
severity of kidney injury and fibrosis (Rodgers et al. 2003; Dennis et al. 2010). In spite 
of the association of macrophages with Alport syndrome, the contribution of 
macrophage infiltration to the progression of Alport syndrome remains elusive. 
Previous studies in Col4a3KO mice with agents attenuating monocyte-macrophage 
recruitment to kidney have yielded equivocal results, with one study showing 
improved renal pathology and mice survival (Ninichuk et al. 2005) and another 
showing no improvement (Clauss et al. 2009). 
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Clodronate is a transient, selective, and systemically acting macrophage-depleting 
agent (Van Rooijen and Sanders 1994; van Rooijen et al. 1996). The phagocytosis-
mediated uptake of clodronate leads to suicidal apoptosis and abrogation of 
macrophage functions in the targeted organs. This depletion strategy has been 
successfully applied to ablate macrophages in other animal models of acute and 
chronic renal diseases (Jo et al. 2006; Kitamoto et al. 2009), but has not yet been 
reported in Alport syndrome mice.  
This study was conducted to investigate i) the effect of macrophage depletion in the 
progression of Alport disease in Col4a3KO mice and ii) any gender-specific 
susceptibility of these mice to Alport disease. Animal weights, renal pathology, and 
renal biomarkers of function and injury were used to assess disease progression over 
time.  
 
1.2 Results 
Body weight in Col4a3KO mice of both genders 
To study the progression of renal disease in male and female Col4a3KO (KO) mice, 
change in body weights are reported in comparison to wild-type (WT) littermates of 
the same sex. Up to the first 7 weeks of life, the weights of KO mice were largely 
indistinguishable from their respective WT littermates (Figure 1.2). After 
 
 
 
 
A              B 
 
Figure 1.2.  Body weights were reduced in male (A) and female (B) Col4a3KO mice as 
compared to WT littermates by 7.3 and 7.9 weeks of age, respectively (n=10 to 15 mice per 
group). 
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approximately 7 weeks of age, both male and female KO stopped gaining weight in 
contrast to their WT siblings, which continued to exhibit gradual increases in body 
weight. At the age of ~7.3 and 7.9 weeks (51 and 55 days), respectively, the male and 
female KO mice demonstrated significant lower body weights as compared to the age- 
and gender-matched WT siblings (12% and 10%, respectively). By 9 weeks of age, the 
male and female KO mice were lighter than age- and gender-matched WT by 
approximately 18% and 11%, respectively.  
 
Change in renal function in Col4a3KO mice of both genders 
To assess whether KO mice exhibit gender-dependent alterations in the onset and the 
kinetics of renal function decline, serum urea nitrogen (BUN) and urinary albumin 
were monitored weekly for both sexes from the age of 5 to 10 weeks. As shown in 
Figure 1.3A, serum BUN levels in 5-weeks old KO mice were comparable to the WT 
littermates with no discernable differences between the genders. However, by 6 weeks 
of age, both male and female KO displayed significantly elevated BUN levels as 
compared to their WT littermates (~2-fold). BUN levels gradually increased in both 
genders of KO mice until 8 weeks of age; at which time a ca. 7-fold increase in BUN 
was measured. By 10 weeks of age, BUN levels were on average 9- and 6-fold higher 
in KO males and females, respectively, compared to their WT littermates. Levels of 
BUN were comparable for female and male KO mice at all measured time points, 
except for weeks 9 and 10. Urinary albumin/creatinine ratios (henceforth referred to as 
albumin) were assessed in KO males and females between 5 to 10 weeks of age 
(Figure 1.3B). Albumin levels increased significantly in 5-week old KO mice with 
approximately 540- and 210-fold increases in males and females, respectively, 
compared to WT littermates. Albumin levels remained elevated over the entire 
observation period in KO, with ca. 580-fold and 1700-fold increases in males and 
females, respectively over WT level by 10 weeks of age. Levels of albumin were 
comparable for female and male KO mice at all measured time points, except for 
weeks 5 and 10. 
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Change in kidney injury biomarkers in Col4a3KO mice 
To investigate kidney injury, levels of neutrophil gelatinase-associated lipocalin 
(NGAL) and kidney injury molecule-1 (KIM-1) were systematically measured and 
normalized to urinary creatinine in KO mice from 6-10 weeks of age. NGAL and 
KIM-1 levels showed marked increases in the week 6 urine samples as compared to 
the age-matched WT mice and these continued to increase gradually throughout the 
study period (Figure 1.3C and D). Approximately 30- and 140-fold increases in NGAL 
were measured in 6-and 9-week old KO, respectively over the WT level. KIM-1 levels 
were increased 3- and 5-fold over WT in 6-and 9-week old KO, respectively. No 
gender differences in NGAL and KIM-1 levels were observed (data not shown). 
A            C 
 
B            D 
 
Figure 1.3.  Increase in renal dysfunction biomarkers (A, B) accompanied an increase in 
kidney injury biomarkers (C, D) in Col4a3KO mice after 5 weeks of age. Serum BUN (A), 
urinary albumin (B), urinary NGAL (C), and urinary KIM-1 (D) levels were significantly 
increased in KO mice at 5-6 weeks of age and continued to increase until the end of the 
monitored period (10 weeks). *, significance vs WT males; #, significance vs WT females. 
(n=3 to 10 mice per group) 
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Renal pathology in male and female Col4a3KO mice 
Pathological examination of kidney tissue from 8 weeks old mice confirmed the most 
prominent histopathological features of Alport syndrome in both female and male KO 
mice (Figure 1.4). Histological examination of hematoxylin/eosin (H&E) (Figure 
1.4A-C) and periodic acid-Schiff (PAS) (not shown) sections showed multifocal to 
diffused processes affecting the cortex and the medullary regions of the kidney. Many 
of the dilated tubules either contained eosinophilic material (casts) or showed 
degeneration/atrophy with short basophilic to coarsely vacuolated epithelial cells. 
Generalized involvement of the glomeruli by variable thickening of the basement 
membrane or segmental to diffused obscuration of the glomerular structure 
(glomerular sclerosis) was also observed. The interstitium was multifocally thickened 
by few cells resembling fibroblasts and more rarely, inflammatory cells. H&E or PAS 
showed increased deposition of collagen at the corticomedullary junction or in the 
vicinity of sclerotic glomeruli. Sirius red stain showed diffused and exaggerated 
deposition of extracellular matrix (ECM) (Figure 1.4D-F). Both genders were affected 
equally by disease progression as indicated by nephropathy score and assessment of 
interstitial fibrosis (Figure 1.4E).  
F4/80 and α-smooth muscle actin (α-SMA) staining showed occurrence of fibrotic 
lesions characterized by infiltrates of F4/80 positive macrophages and α-SMA-positive 
myofibroblasts in KO mice of both genders (data not shown). Morphometric 
quantification confirmed a significant increase in macrophage and myofibroblast 
infiltrates in the KO kidney (Figure 1.5A). Male and female kidneys were similarly 
affected with 12-fold and 36-fold increases respectively, in F4/80 and 12- and 13-fold 
increases respectively, in α-SMA staining as compared to age-matched WT mice. To 
correlate protein data with transcriptional expression the mRNA expression of 
Col3A1, F4/80 and Thy-1 genes were investigated by real-time PCR (Figure 1.5B). 
Previous studies have shown Col3A1 and Thy-1 (CD90) transcripts to be highly 
elevated in KO kidney (Sampson et al. 2001). Thy-1 has also been described to co-
localize with α-SMA-positive myofibroblasts in several organs, including kidney, and 
represents a useful expression marker for myofibroblasts (Clayton et al. 1997; Dudas 
et al. 2007). In agreement with previous studies, significant changes in Col3A1, F4/80 
and Thy-1 gene expression are reported here, with 44-, 9-, and 18-fold increases in KO  
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     A       WT male    B       KO male           C KO female
 
 
     D       WT male    E       KO male           F KO female 
 
    E 
 
Figure 1.4.  No differences in renal pathology noted between male and female 
Col4a3KO kidney at 8 weeks of age. (A-C) H&E-stained cortex. KO mice showed 
glomerulosclerosis (circled) to varying degrees, with some glomeruli appearing less 
affected and almost normal (stars). (D-F) Sirius red-stained cortex. WT showed a thin 
delineation of Sirius Red-stained fibers around tubuli, in KO this was variably thickened.. 
(E) Nephropathy score assessed in H&E- and PAS-stained sections and quantitative 
analysis of Sirius Red positive interstitial fibrosis demonstrated significantly increased 
nephropathy and interstitial fibrosis in KO mice compared to WT littermate controls of the 
same sex with no differences between female and male mice. Scale bar 100 µm. 
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male kidney relative to wild-type mice and similar extent of increases observed in KO 
females. The gene expression and protein composition data are consistent with the 
histopathological changes with no discernable differences in disease onset or 
progression between female and males KO mice. This observation and the absence of 
gender-associated weight differences with disease progression justified the use of only 
male mice henceforth in this study. 
A 
 
B
 
Figure 1.5.  Protein and mRNA expression of collagen, macrophages, and 
myofibroblasts markers were increased in 8 weeks old Col4a3KO mice with no 
significant differences between male and female mice. (A) Morphometric analysis of 
F4/80-positive macrophages and α-SMA-positive myofibroblasts showed a significant 
increase was observed in both male and female KO kidney, compared to WT littermate 
controls of the same sex. The degree of changes was comparable in animals of both genders 
with the exception of the F4/80 positive macrophage area being about two-fold higher in 
female than in male KO mice. (B) Real-time PCR analysis of Col3A1, F4/80 and Thy-1 
mRNA showed marked upregulation in the expression of these genes in both male and 
female KO kidney, compared to WT littermate controls of the same sex. The magnitude of 
changes was comparable in animals of both genders. *: significance vs WT males; #: 
significance vs WT females. n=3 to 8 mice per group. 
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Effect of macrophage-depletion on kidney function and fibrosis 
To investigate the contribution of macrophages to Alport disease, kidney macrophages 
were depleted in Col4a3KO mice using clodronate liposomes (KO+CL) and compared 
to PBS liposome-treated mice (KO+PBSL), untreated Col4a3KO (KO), and wild-type 
(WT) littermate mice (Figure 1.6A). Treatment with CL and PBSL was initiated in 4-
weeks old mice since disease onset measured by proteinuria was not observed until 5 
weeks of age (Cosgrove et al. 1996). Diffused infiltration of F4/80 macrophages in 
KO+PBSL kidneys was effectively inhibited through the administration of CL (Figure 
1.6B). After 4 weeks of treatment with KO+CL, 70% macrophage depletion was 
observed as demonstrated by protein and gene expression analyses (Figure 1.6C and 
D).  
The effect of macrophage depletion on the onset and severity of Alport disease was 
studied in Col4a3KO mice by assessing renal function and interstitial fibrosis. KO+CL 
mice progressed to renal failure with similar degree and severity as KO+PBSL or KO 
mice (Figure 1.7). Kidney function was not improved as indicated by comparable 
levels of serum BUN and urine albumin, between the KO+CL and KO+PBSL mice 
within the 4-8 week time span (Figure 1.7A and B). A transient change in urinary 
albumin was measured only in 7-weeks old KO+PBSL mice and could account for 
significantly lower levels in KO+CL mice. No effect of macrophage depletion on the 
levels of NGAL and KIM-1 were observed in 8-week old mice (Figure 1.7C and D).  
Histological analyses did not reveal any differences in renal pathology, with all KO 
mice showing a similar extent in the severity and distribution of chronic renal 
pathology, regardless of the treatment received (Figure 1.8 and 9). The overall 
nephropathy score was not remarkably different following macrophage depletion 
(Figure 1.8E). A minimal decrease in glomerular sclerosis was observed in KO+CL 
mice when compared to KO mice, however there was no reduction when compared 
with the KO+PBSL mice (Figure 1.8E). Similarly, no reduction in α-SMA-positive 
cells was observed in KO+CL mice when compared to KO+PBSL mice (Figure 1.9C-
E). The elevated expression of profibrotic genes (Figure 1.9F) as wells as genes of 
ECM remodeling (Figure 1.9G) and inflammation (Figure 1.9H) did not differ in KO 
mice from different treatment groups.  
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A 
 
 
B     KO + PBSL     KO + CL 
     
 
C    D 
 
Figure 1.6.  Clodronate liposome mediated macrophage depletion in Col4a3KO mice. 
(A) Col4a3KO male mice were dosed intraperitonally with CL (KO+CL) or PBSL 
(KO+PBSL) as control. Animals were entered in the study at the age of 4 weeks and were 
continually dosed until the age of 8 weeks. Injections were repeated every second day, except 
for the first two doses, which were injected on consecutive days. (B-D) CL significantly 
reduced F4/80 positive macrophage infiltrates in KO kidneys at the age of 8 weeks. (B, C) 
Representative images and quantitative assessment of F4/80 stained macrophages in kidney 
sections revealed marked reduction in macrophage infiltrates following CL dosing in KO 
mice. (D) Real-time PCR analysis of F4/80 mRNA expression in KO+CL, KO+PBSL, KO, 
and WT littermates at the age of 8 weeks. Significant reduction in F4/80 mRNA expression 
following CL dosing was observed. Scale bar: 100 µm. n=5 mice per group. CL: clodronate 
liposomes; PBSL: PBS liposomes. 
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Although monocytes-macrophages are reported to be one of the cell types expressing 
TGF-β1 in the mouse Alport kidney (Rodgers et al. 2003), reduction of macrophages 
by 70% did not affect TGF-β1 expression, which appear to be increased 4-fold in KO 
mice as shown in this study (Figure 1.9F) as well as in other studies (Sampson et al. 
2001). This indicates that macrophages are likely not the major cellular source of TGF-
β1 in the Col4a3KO kidney.  
  
A           B 
 
C    D 
 
 
Figure 1.7.  Macrophage depletion did not improve renal function in Col4a3KO mice.  
(A-D) CL treatment did not delay or slow down renal failure measured by serum BUN and 
urinary albumin, NGAL, and KIM-1. (A, B) Similar increase in BUN and ACR was detected 
at all time points in KO+CL compared to KO+PBSL or KO mice. (C, D) KO+CL mice 
showed similar increase in urinary NGAL and KIM-1 as KO+PBSL or KO mice at the age of 8 
weeks. n=5 to 9 mice per group. CL: clodronate liposomes; PBSL: PBS liposomes. 
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A      KO + PBSL  B    KO + CL 
 
 
C      KO + PBSL  D    KO + CL 
 
 
E 
 
Figure 1.8.  Macrophage depletion did not improve renal pathology in Col4a3KO mice. 
Kidney pathology was comparable between KO+PBSL and KO+CL. Panels A (H&E) and C 
(PAS) show tubular pathology (atrophy, degeneration/regeneration and eosinophilic casts) in 
KO+PBSL; panels B (H&E) and D (PAS) show comparable tubular pathology in KO+CL. 
Incidence of sclerotic glomeruli was comparable between KO+PBSL and KO+CL (circle = 
sclerotic glomeruli; star = normal-appearing glomeruli), with many glomeruli showing variable 
extent of changes from normal to sclerotic appearance. (E) Semi quantitative histologic 
assessment of nephropathy and sclerotic glomeruli revealed no significant differences between 
KO, KO+PBSL or KO+CL mice. Scale bar 100 µm. CL: clodronate liposomes; PBSL: PBS 
liposomes. 
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A       KO + PBSL         B          KO + CL 
 
C       KO + PBSL         D          KO + CL 
 
E           F 
 
G         H 
 
Figure 1.9.  Macrophage depletion showed no effect on interstitial fibrosis and 
myofibroblast accumulation in Col4a3KO mice. A (Sirius red) and C (α-SMA) show 
increased deposition of Sirius red stained fibrotic tissue and α-SMA cells in the interstitium of 
KO+PBSL; B (Sirius red) and D (α-SMA) show an increased staining of the interstitium in 
KO+CL that was comparable to KO+PBSL (circle: sclerotic glomeruli; star: normal-appearing 
glomeruli). Glomerular crescents (arrows) were also observed occasionally in glomeruli. (E) 
Morphometric analysis of α-SMA stained myofibroblasts confirmed no discernable effect of 
CL treatment on myofibroblasts deposition. (F-H) Expression of profibrotic genes (F), genes 
for ECM remodeling (G) and inflammation (H) is comparable in KO+PBSL and KO+CL mice. 
Scale bar 100 µm. CL: clodronate liposomes; PBSL: PBS liposomes. 
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1.3 Discussion 
Gender-independent progression of kidney disease in Col4a3KO mice.  
The human autosomal form of Alport syndrome has been shown to affect both males 
and females equally (Mochizuki et al. 1994). However, little is known about gender 
differences in renal disease progression in Col4a3KO mice. This study demonstrates 
that the severity of disease onset and progression is not dependent upon gender of 
Col4a3KO mice. Thus, both female and male Col4a3KO mice are equally predictive of 
Alport syndrome and can be used to study pathogenic mechanisms and to evaluate 
experimental therapies.  
NGAL and KIM-1 are produced by kidney in response to tubular epithelial damage 
(Ichimura et al. 1998; Mishra et al. 2003). Urinary NGAL and KIM-1 were 
systematically evaluated in Col4a3KO mice as markers of kidney injury along with 
BUN and urinary albumin, the standard measures of renal function. NGAL and KIM-1 
were markedly elevated during early to late stage disease progression in Col4a3KO 
mice, supporting their role as markers of kidney damage. A similar pattern of increased 
NGAL excretion was also found in dogs with the X-linked form of Alport syndrome 
(Nabity et al. 2012) suggesting a conserved pattern of NGAL expression in Alport 
nephropathy across multiple species. Further investigation would need to confirm the 
use of NGAL and KIM-1 as translational biomarkers of human autosomal recessive 
Alport disease. 
 
Macrophages depletion does not alleviate disease progression in kidney of Alport 
mice.  
To test the hypothesis that macrophage depletion would improve kidney function and 
renal pathology in Alport disease, Col4a3KO male mice were treated with CL. CL 
treatment, started prior to onset of disease as evidenced by clinical pathology and 
continued throughout the study, effectively reduced macrophage recruitment to the 
Alport kidney by ~70%. However, the reduction of macrophages was not associated 
with improvement of histological or functional renal injury in Col4a3KO mice. 
These data are in agreement with a previous study, which showed that significant 
inhibition of macrophage infiltration alone (via MCP-1/CCL2 blockage using anti-
CCL2 spiegelmers) led to the reduction of glomerular and interstitial macrophages by 
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50% and 30%, respectively, but was not associated with improving renal pathology or 
prolonging the life span of Col4a3KO mice (Clauss et al. 2009). Although 70% 
macrophage depletion was achieved in the current study, any compensatory role by the 
remaining 30% macrophages in driving renal damage in Col4a3KO mice cannot be 
eliminated. Macrophage populations are not all the same, as shown by in vitro studies 
that differentiate between two major populations; M1 and M2, according to their 
response to specific cytokines. Both renoprotective and damaging effects have been 
attributed to M2 macrophages. Adoptive transfer of M2 macrophages has been shown 
to resolve inflammation and repair injury in many fibrosis models of kidney injury 
(Wang and Harris 2011). Similarly the ablation of macrophages during the M2 
predominance is shown to slow kidney resolution in the reperfusion injury model (Lee 
et al. 2011). On the contrary, conditional ablation of M2 macrophages defined as 
Ly6Clow has been shown to be antifibrotic in unilateral ureteral obstruction (UUO) 
model of kidney fibrosis (Lin et al. 2009). Clodronate treatment can kill activated M2 
macrophages (Wu et al. 2014) but the extent to which specific macrophage sub-
populations are affected by clodronate or the contribution of these subpopulations in 
Alport syndrome has not been investigated in this or previous studies. The extent of 
macrophage depletion in kidney obtained in Col4a3KO mice was similar to that 
obtained in UUO where CL-mediated macrophage depletion prior to the UUO injury 
resulted in the amelioration of renal fibrosis (Kitamoto et al. 2009).  
Partial depletion (25%) of interstitial macrophages via the antagonism of chemokine 
(C-C motif) receptor 1 (CCR1), associated with a reduction of transendothelial 
migration of blood leukocytes, is reported to have a moderate effect on renal function 
as well as survival of Col4a3KO mice (Ninichuk et al. 2005). The results from our 
study indicate that macrophage depletion by clodronate treatment neither ameliorated, 
nor potentiated fibrosis in Col4a3KO mice. A possible explanation for the varied 
results regarding the impact of macrophage depletion in the progression of Alport 
disease is that a broad spectrum of leukocytes and not exclusively the 
monocyte/macrophage population are important for disease progression. In agreement 
with this, interstitial T-cell infiltrates are observed in renal biopsies of patients with 
Alport syndrome and are shown to inversely correlate with renal function of patients 
with Alport syndrome (Jedlicka et al. 2010). This hypothesis is also supported by 
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observations from previous studies, in which Col4a3KO mice either crossed with 
RAG-1 deficient mice to lack mature lymphocytes or treated with a statin inhibitor to 
reduce both lymphocytes and macrophages alleviated Alport kidney pathology and 
prolonged survival. Specifically, Col4a3KO mice crossed with RAG-1-deficient mice 
showed reduced tubulointerstitial inflammation and fibrosis without improving the 
glomerular injury (Lebleu et al. 2008), while treatment with a statin inhibitor, had 
antifibrotic effect and prolonged the survival of Col4a3KO mice (Koepke et al. 2007). 
The data presented here strongly suggest that inhibition of macrophage infiltration 
alone is not sufficient to ameliorate progression of Alport syndrome in Col4a3KO 
mice and collectively with data from other studies (Kruegel et al. 2013; Gross et al. 
2014) suggest that, targeting multiple immune cell populations will likely be more 
effective in checking kidney disease progression.  
 
1.4 Conclusions 
Alport syndrome is a genetic disease of collagen IV (α3, 4, 5) resulting in defective 
assembly of glomerular basement membrane leads to renal failure. Col4a3KO mice are 
an established genetic model of autosomal recessive Alport syndrome. No sex 
differences in the evolution of body mass loss, renal pathology, biomarkers of tubular 
damage NGAL and KIM-1, or deterioration of kidney function were observed during 
the life span of Col4a3KO mice. These findings confirm that, similar to human 
autosomal recessive Alport syndrome, female and male Col4a3KO mice develop renal 
failure at the same age and with similar severity. The specific contribution of 
macrophage infiltration to Alport disease, one of the prominent features of the disease 
in human and Col4a3KO mice, remains unknown. This study shows that depletion of 
kidney macrophages in Col4a3KO male mice by administration of clodronate 
liposomes, prior to clinical onset of disease and throughout the study period, does not 
protect the mice from renal failure and interstitial fibrosis, nor delay disease 
progression. These results suggest that therapy targeting macrophage recruitment to 
kidney is unlikely to be effective as treatment of Alport syndrome. 
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1.5 Materials and methods 
Mice 
Col4a3KO mice with 129/SvJ background (129-Col4a3tm1Dec/J) were purchased from 
The Jackson Laboratory and maintained as a heterozygous colony. All animal studies 
were approved by the animal care committee of the Canton Basel-Stadt, Switzerland. 
Animal studies 
The gender and genotype of Col4a3KO mice was determined at 3 to 4 weeks of age. 
Both genders of Col4a3KO mice and their wild-type littermate controls of the same 
sex were used for the experiments unless stated differently. To analyze the gender 
effect, the study was initiated in 4 weeks old mice and terminated when the mice 
reached the age of 9-10 weeks or lost more than 20% of their body weight. The study 
with clodronate liposomes (CL) or PBS liposomes (PBSL) (Encapsula NanoSciences) 
was initiated in 4 week old mice and terminated when the mice reached the age of 8 
weeks. Liposomes (200 µl/mouse) were injected intraperitoneally for 2 consecutive 
days, followed by every second day of administration until end of the study.  
Urine and blood analysis 
Urine was sampled weekly and analyzed for albumin, creatinine, NGAL, and KIM-1. 
Albumin was measured using the Albuwell M kit (Exocell) and normalized to 
creatinine levels analyzed by Aution urine analysis system (Arkray). 
Mouse KIM-1 was analyzed with an immunoassay using an anti-mouse rat monoclonal 
and an anti-mouse goat polyclonal as the capture and detection reagent, respectively 
(R&D Systems) on an SI6000 from Mesoscale Discovery (MSD). 30 µL of capture 
antibody (4 µg/ml in PBS) was incubated overnight on MSD standard plates at 4°C. 
The plate was washed 3× with PBS followed by the addition of 25 µl of urine (1:4 
dilution in MSD diluent 5) and incubated for 1 h at RT. Incubation with the secondary 
antibody for 1 h was followed by a wash and application of MSD Sulfo-Tagged anti-
goat antibody for 1 h. After another wash, 150 µl of MSD Read Buffer T was added, 
and the plates read on an MSD SI 6000. Data were analyzed on MSD Discovery 
Workbench software. NGAL and Albumin were assayed at 1:1000 and 1:100 dilutions, 
respectively as per manufacturer’s instruction using kits from Bioporto and Abnova, 
respectively. KIM-1 and NGAL were normalized to creatinine analyzed using the 
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Urinary Detection Kit (Arbor Assays) at a 1:25 dilution in H2O and assayed as per 
manufacturer’s instructions. Plates were read on a SpectraMax M5 (Molecular 
Devices) and analyzed with SoftMax Pro v5 (Molecular Devices). 
Blood was sampled every two weeks from V. sublingualis into Microtainer tubes (BD 
biosciences) under isoflurane anesthesia. Serum was used to measure blood urea 
nitrogen by Spotchem EZ Automated analyzer and Spotchem ll reagent strip (Arkray). 
Immunohistochemistry and histology 
Kidneys were fixed in 10% buffered formalin for 48 h at RT and processed for 
embedding in paraffin using standard procedures. Immunohistochemical staining for 
F4/80 was performed using an automated Ventana Discovery XT Platform (Ventana 
medical systems). Sections, pretreated with protease (Ventana), were incubated with 
Peroxidazed 1 (Biocare medical) and stained with anti-F4/80 antibodies (1:100; ABD 
Serotec) for 48 min. Reaction was detected with the OmniMap anti-Rt HRP (Ventana) 
and ChromoMap DAB Kit (Ventana), followed by counterstaining with hematoxylin. 
For α-SMA staining, sections were treated with 0.5% H2O2 in methanol for 20 min, 
followed by 20 min incubation with anti-α-SMA antibodies (1:25; DAKO), detection 
by ARK™ Peroxidase kit (DAKO), and counterstaining with hematoxylin. For Sirius 
red staining, Picrosirius Red solution and 0.04% Light Green solution (EMS) were 
used according to the manufacturer’s recommendations. Sections were stained with 
hematoxylin and eosin (H&E) and Periodic acid-Schiff (PAS) using standard 
protocols. Digital images were obtained with a ScanScope XT system (Leica).  
Quantification of immunohistochemical staining 
Area %, defined as stained area per total surface area, was obtained with Image Scope 
software (Leica) using the Positive Pixel Count algorithm. 
Histopathological evaluation 
Glomerular sclerosis percentages were assessed by counting the number of segmental 
to global sclerotic glomeruli, and other glomeruli with variable changes but with patent 
vessels on H&E sections. Tubulointerstitial change indices were obtained from H&E 
slides as the mean value between the semiquantitive score assigned to each change 
(namely tubular degeneration/atrophy, tubular dilation, tubular casts, and interstitial 
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fibrosis, with four-grade score system related to the extent of the change: 0, no lesion; 
1, < 25% affected tubuli; 2, 25 to 50 % affected tubuli; 3, 51 to 75% of affected tubuli; 
4, > 75% affected tubuli). 
Real time qRT-PCR analysis 
Kidney tissue was snap frozen in liquid nitrogen and homogenized with the FastPrep-
24 (MP Biomedicals) system. RNA was isolated using an RNeasy purification kit 
(Qiagen) according to the manufacturer’s recommendations. Quantitative real-time 
PCR was performed for genes of interest and 18s rRNA using Taqman Universal 
Master Mix and the ABI Prism 7900 HT Sequence Detection System (Applied 
Biosystems). Gene expression was normalized to 18s rRNA expression.  
Statistical analysis 
The results are presented as mean ± SEM. Unpaired t test was used for the 
comparisons between two groups. * or #: p< 0.05; ** or ##: p <0.01; *** or ###: p 
<0.001. For repeated measurements, data were analyzed using mixed model data 
analysis followed by posthoc Fisher’s LSD test. 
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2 
Characterization of DPP9 protease dead mutant 
mice 
2.1 Introduction 
Dipeptidyl peptidase 9 (DPP9) is an intracellular serine protease of largely unknown in 
vivo functions. DPP9 was identified in silico by Abbott et al. (Abbott et al. 2000) with 
the genomic structure cloned and characterized by Olsen and Wagtmann in 2002 
(Olsen and Wagtmann 2002). As a member of DPP4 and S9b gene family, DPP9 and 
the related DPP4, DPP8, and Fibroblast Activation Protein (FAP) have a rare ability to 
cleave N-terminus of peptide substrates at post-proline bond in the penultimate 
position. A conserved catalytic triad of serine, aspartate, and histidine in an active site 
is essential for their activity and the unique substrate specificity (Abbott et al. 2000; 
Olsen and Wagtmann 2002; Ajami et al. 2004). Human DPP9 shares 93% and 94% 
amino acid similarity with mouse and rat DPP9, respectively. DPP8 is the closest 
relative of DPP9 with 79 % similarity and 61% identity in amino acid level (Ajami et 
al. 2004). DPP8 and DPP9 are localized to human chromosomes 15q22 and 19p13.3, 
respectively (Olsen and Wagtmann 2002). A high degree of homology together with 
the conservation of clusters of paralogous genes between human chromosomes 
15q24→26 and 19p13.3→p12 (Carim-Todd et al. 2000) suggests that DPP8 and DPP9 
arise in an ancestral duplication of a chromosomal segment. Biochemical properties of 
DPP8 and DPP9 are very similar including substrate specificity and catalytic efficiency 
against synthetic peptides (Bjelke et al. 2006; Geiss-Friedlander et al. 2009; Tang et al. 
2009). Moreover, both can process DPP4 substrates glucagon-like peptide-1 (GLP-1), 
GLP-2, neuropeptide Y (NPY) and peptide YY in cell extract (Bjelke et al. 2006) and 
NPY in intact cells (Lu et al. 2011). Recently, adenylate kinase 2 and calreticulin were 
identified as natural substrate candidates for DPP8 and DPP9 using a cytosol-wide 
proteomic screen (Wilson et al. 2013). The remarkable substrate overlap together with 
no unique cleavage sites identified so far for DPP8 or DPP9, led to the speculation that 
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there may be functional redundancy between the two enzymes (Tang et al. 2009; 
Wilson et al. 2013).  
A functional role of DPP9 in regulation of cell survival, migration and apoptosis 
emerges from in vitro studies, however, no supportive in vivo evidence has been 
provided so far. Impaired cell adhesion, migration and wound healing with increased 
spontaneous apoptosis independent of DPP9 enzyme activity is reported in DPP9 
overexpressing HEK293T cells (Yu et al. 2006). siRNA mediated DPP9 knockdown 
and pharmacological inhibition of DPP9 enzyme in Huh7 cells leads to similar 
functional outcome with impaired cell adhesion and migration associated with 
decreased expression of adhesion signaling pathway in the absence of cell death 
(Zhang et al. 2015). Overexpression of enzyme active DPP9 in HepG2 and Huh7 cells 
attenuates epidermal growth factor (EGF)-mediated PI3K/Akt signaling resulting in 
augmented apoptosis and suppressed cell proliferation in HepG2 cells (Yao et al. 
2011). On the contrary, DPP9 down-regulation enhanced NPY-induced cell death in 
Ewing sarcoma family of tumor (Lu et al. 2011) and DPP8/9 inhibition induced 
spontaneous apoptosis of primary macrophages in NPY independent manner 
(Matheeussen et al. 2013). Different and sometimes contradictory responses of DPP9 
imply that the role of DPP9 varies depending on the cell type and the disease. DPP8 
and DPP9 are ubiquitously expressed (Abbott et al. 2000; Olsen and Wagtmann 2002; 
Yu et al. 2009) including leukocytes (Ajami et al. 2004; Maes et al. 2007; Yu et al. 
2009; Chowdhury et al. 2013) and upregulated in activated human and rodent 
lymphocytes (Bank et al. 2011; Chowdhury et al. 2013). Anti-proliferative effects of 
DPP8/9 inhibition are observed after activation of human and rodent T-cells in vitro 
(Lankas et al. 2005; Reinhold et al. 2009). Although, both DPP8 and DPP9 are 
expressed in macrophage-rich regions of human altherosclerotic plaques, only DPP9 is 
upregulated in monocytes differentiated macrophages and loss of DPP9 activity 
decreases proinflammatory cytokines secretion in activated macrophages in vitro 
(Matheeussen et al. 2013). Furthermore, the cytoplasmic RU134-42 antigenic peptide 
was recently identified as in vivo substrate for DPP9 but not DPP8 implying a role of 
DPP9 in antigen presentation (Geiss-Friedlander et al. 2009). In vivo study revealed 
immune toxicity attributed to DPP8/9 inhibition and associated with 
thrombocytopenia, reticulocytopenia and splenomegaly (Lankas et al. 2005). Contrary 
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to this, a different chemical class of cell permeable DPP8/9 inhibitors is reported to 
have a good safety profile in rodents (Wu et al. 2009). This further emphasizes the 
importance of selective targeting of DPP8 or DPP9 enzymes in shedding light on their 
biology. Recently published catalytically inactive DPP9 knock-in mice are neonatally 
lethal, the cause of which is unknown (Gall et al. 2013). This study was conducted to 
investigate the cause of neonatal death of DPP9 knock-in mice and the role of DPP9 
enzyme in mouse immune system. 
2.2 Results 
Serine to alanine point mutation (S729A) in the catalytic domain of DPP9 gene 
results in loss of DPP9 enzymatic activity in mice  
To assess the biological relevance of the DPP9 protease activity, we generated 
genetically modified mice by homologous recombination with a targeting vector 
carrying a TCC to GCC mutation encoding a catalytically inactive S729A mutant of 
the DPP9 protein (Figure 2.1A). Successfully targeted ES cells were identified by 
Southern blot (Figure 2.1B). Mice heterozygous for the mutation (DPP9+/ki) were 
healthy and fertile, and crossed to obtain homozygous mice (DPP9ki/ki). The mutant 
DPP9 gene was distinguished from the wild type DPP9 gene by genomic PCR 
genotyping (Figure 2.1C). To confirm that catalytically active DPP9 protein is indeed 
absent in DPP9ki/ki mice, DPP9 enzyme activity was measured in brain tissue 
homogenates from newborn mice (P1) because of the high DPP9 protein and mRNA 
expression in nervous system during mouse neonatal development as shown by others 
(Yu et al. 2009) and confirmed by our study (Figure 2.2). We utilized activity based 
proteomics with biotinylated fluorophosphonate referred to as FP-biotin used as an 
activity based probe (ABP). FP-biotin covalently binds to catalytic serine of active 
serine hydrolases in an activity-dependent manner and does not bind to proteolytically 
inactive enzymes (Liu et al. 1999). FP-biotin reactive proteins from mouse brain were 
selectively enriched using streptavidin beads and detected by SDS-PAGE/western blot 
using specific antibodies. As shown in Figure 2.1D, anti-DPP9, DPP8 and PEP 
antibodies recognized the respective human recombinant proteins (lane 1-3). ABP pull 
down of human DPP9 (lane 4) and DPP8 (lane 5) recombinant proteins, used to 
validate the assay, confirmed the detection of active serine proteases. In ABP pull 
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down of DPP9+/+ mouse brain lysate, two proteins at 98kDa and 100kDa are identified 
with anti-DPP9 antibody (lane 6). 98kDa protein was absent while 100kDa protein 
remained in ABP pulled down of DPP9ki/ki mouse brain lysate (lane 7).  
 
 
Figure 2.1.  Loss of DPP9 enzymatic activity in mice by serine to alanine point mutation 
(S729A) in the catalytic domain of DPP9 gene. (A) Generation of DPP9ki/ki mice. The 
targeting vector carries a TCC GCC mutation (nucleotide 97 – 99 of exon 18 of the DPP9 
gene) leading to a S729A mutation in the DPP9 protein. A neomycin resistance gene (neoR), 
flanked by flippase recombinase target (F) sites, is removed by crossing with flippase 
recombinase expressing mice. Southern probe, PCR primers used for screening recombinant 
ES cells and genotyping are indicated. Restriction enzyme cleavage sites: S, SacI; N, NotI. 
Recombinase specific sites: L, LoxP; F, FRT. (B) Southern blot of Sac I-digested genomic 
DNA from the targeted ES cells. Predicted size of the DNA fragment is 7890 bp. M: marker. 
(C) PCR genotyping with set of primers that flank the loxP sites of targeted allele give a 
product of 180bp in DPP9+/+, 200bp in DPP9ki/ki, and 180bp and 200bp in DPP9+/ki mice. 
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Since DPP9 and DPP8 are highly homologous proteins and anti-DPP9 antibody cross 
react with human DPP8 recombinant proteins (lane 2), we speculated that the 
remaining 100kDa band represents active DPP8 protein. To test this hypothesis, we 
utilized DPP8 S749A knock-in mice (DPP8ki/ki) which were generated using the 
similar strategy as DPP9ki/ki mice. Indeed, in ABP pull down of DPP8ki/ki mouse brain 
lysate, 100kDa band (lane 9) was absent when detected with anti-DPP8 antibody while 
98kDa protein remained and was detected with anti-DPP9 antibody (line 9). These 
results demonstrate that 98kDa and 100kDa bands represent active DPP9 and DPP8 
protein, respectively. Furthermore, no compensatory upregulation by DPP8 active 
enzyme was detected in DPP9ki/ki brains as demonstrated by similar levels of DPP8 
enzyme activity in DPP9+/+ and DPP9ki/ki brain lysates (Figure 2.1E). Taken together, 
these data demonstrate loss of DPP9 enzymatic activity and the lack of compensatory 
regulation by DPP8 enzymatic activity in newborn DPP9ki/ki mice. 
 
Neonatal lethality due to suckling defect in DPP9ki/ki mice 
DPP9ki/ki mice were born at the expected Mendelian ratio, but died during the first 
postnatal day (P1) (Figure 2.3A). The overt appearance of newborn DPP9ki/ki mice was 
normal. They were able to breathe and move, suggesting no overt respiratory and 
sensory motor defects. However, body weight of DPP9ki/ki mice measured at ~12 h 
after birth was lower (~7.5%) compared to DPP9+/+ littermates (Figure 2.3B). 
(D) Loss of DPP9 enzymatic activity in DPP9ki/ki mouse brain lysate detected with activity-
based probe (ABP). Anti-DPP9, DPP8 or PEP antibodies recognize human recombinant 
proteins at ~ 98, 100, and 75 kDa, respectively (lane 1-3). PEP is used as a loading control. 
ABP pull down using human DPP9 and DPP8 recombinant proteins as positive controls 
detects enzymatically active recombinant proteins (lane 4, 5). Anti-DPP8 antibody detects 
DPP8 recombinant protein only (lane 2, 5) in contrast to anti-DPP9 antibody which 
recognizes both DPP8 and DPP9 recombinant proteins (lane 2, 4, 5). In ABP pull down of 
wild-type brain lysate two bands (~ 98kDa and 100kDa) are detected with anti-DPP9 
antibody and one band (~ 100kDa) with anti-DPP8 antibody (lane 6, 8). 98kDa band is 
absent in ABP pull down of DPP9ki/ki brain lysates (lane 7) and 100kDa band is absent in 
ABP pull down of DPP8ki/ki brain lysates (lane 9) demonstrating that 98kD and 100kDa band 
represent enzymatically active DPP9 and DPP8, respectively and that enzymatically active 
DPP9 is absent in DPP9ki/ki mice. (E) Comparable DPP8 enzymatic activity in DPP9ki/ki and 
DPP9+/+ brain at P1 analyzed by quantitative assessment of ABP assay. 
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Figure 2.2.  High DPP9 mRNA and protein expression in mouse nervous system at P1. 
(A, B) Specificity of DPP9 antisense probe (A) anti-DPP9 antibody (B) is validated by in situ 
hybridization and immunohistochemistry in HEK293 cells transfected with mouse DPP8 or 
DPP9. (C) In situ hybridization analysis of DPP9 mRNA expression in P1 wild-type mouse 
reveals high DPP9 expression in nervous system structures including brain (as shown for 
cortex, hippocampus, thalamus, and Mo5), trigeminal nerve, spinal cord, and DRG. (D) High 
DPP9 protein signal in P1 wild-type mouse nervous system structures including brain (as 
shown for cortex, hippocampus, thalamus, and Mo5), trigeminal nerve, spinal cord, and DRG 
by immunohistochemistry. Mo5, trigeminal motor nucleus; DRG, dorsal root ganglion. Scale 
bars: 50 µm (unless stated otherwise). 
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Figure 2.3.  DPP9ki/ki mice die shortly after birth due to impaired suckling response. (A) 
DPP9ki/ki mice are born at the expected Mendelian ratio but do not survive the first postnatal 
day (P1). P0, time of birth. (B) Body weight of DPP9ki/ki mice measured at ~12 h after birth is 
slightly lower than that of DPP9+/+ littermates. (C) DPP9ki/ki newborn mice, unlike DPP9+/+ 
littermates, lack milk in the stomach (arrow) as visualized macroscopically and on H&E-
stained sections. Inset shows presence of milk in DPP9+/+ and its absence in DPP9ki/ki mice 
which contain in stomach only exfoliating epithelial cells. Stomach develops normally in 
DPP9ki/ki mice as analyzed on E18.5 and P1. Scale bar upper panel: 1 cm, lower panel: 500 
µm, inset: 50 µm. (D) Rescue of DPP9ki/ki mice by hand feeding. DPP9ki/ki mice manually fed 
every 2 h for 24 h survive during the entire duration of the study in contrast to mother reared 
DPP9ki/ki mice which die within 12-18 h after birth. (E) Analysis of suckling behavior reveals 
defects in nipple attachment but normal nipple finding and jaw movement responses in 
newborn DPP9ki/ki mice. (F) Snapshots of video recording demonstrate weak attachment of 
newborn DPP9ki/ki mice to mother’s nipple while being pulled away from mother.  
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Furthermore, all DPP9ki/ki mice lacked milk in their stomachs even within 18 h after 
birth as demonstrated visually by the absence of the milk spot and on H&E-stained 
stomach sections (Figure 2.3C). Only exfoliated epithelial cells and mucus were 
observed in stomach of newborn DPP9ki/ki mice, their stomach, however, developed 
normally as shown by the analysis of E18.5 embryos (Figure 2.3C). To examine 
whether the neonatal lethality of DPP9ki/ki mice is caused by defects in suckling 
response, newborn mice were separated from the mother and manually fed with 
artificial cat milk every 2 h for 24 h. Manually-fed DPP9ki/ki mice survived during the 
entire experimental period whereas mother-reared DPP9ki/ki mice died within 12-18 h 
after birth, demonstrating that suckling defect is the primary cause of neonatal lethality 
of DPP9ki/ki mice (Figure 2.3D). Abnormal suckling response can be a consequence of 
defects in energy homeostasis (Turgeon and Meloche 2009). Comparable fasted blood 
glucose levels measured at 3 h after birth with 54 ± 15 mg/dL vs 61 ± 14 mg/dL in 
DPP9+/+ and DPP9ki/ki mice, respectively indicated, however, normal energy level in 
DPP9ki/ki mice. The suckling response is a complex behavior that includes finding 
mother’s nipple, nipple attachment, suckling with rhythmic movements of the jaw and 
tongue, and milk withdrawal (Blass and Teicher 1980). To examine the feeding 
behavior, DPP9ki/ki and littermates pups were placed alone with anesthetized mother to 
feed and video recorded. DPP9ki/ki pups were able to locate nipple and showed 
rhythmic jaw movements indicating normal development of olfactory and sensory-
motor system involved in suckling response (Figure 2.3E). In accordance with this, 
E10.5 DPP9ki/ki embryos showed well preserved gross morphology of trigeminal 
sensory nerve (V) and glossopharyngeal sensory nerve (IX) which relay sensation from 
the face and the tongue (Figure 2.4A). Furthermore, discrete neuronal patterns 
(barrelettes) were formed in spinal trigeminal nucleus from newborn DPP9ki/ki mice 
indicating normal interaction between the primary vibrissal afferents and second-order 
neurons innervating tactile sensation of face (Figure 2.4B). Comparable populations of 
motor neurons in brainstem nuclei innervating jaw (trigeminal motor nucleus; Mo5), 
face (facial motor nucleus; 7N), and tongue (hypoglossal nucleus; 12N) muscles 
(Figure 2.4C) together with normal development of neuromuscular junctions in 
masseter and tongue muscles of DPP9ki/ki newborn mice (Figure 2.4D and E) provide 
evidence that motor system is intact in DPP9ki/ki mice.  
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Figure 2.4.  Normal development of sensory and motor neuronal pathways in DPP9ki/ki 
mice. (A) Normal cranial nerve development in DPP9ki/ki at E10.5. Whole-mount 
neurofilament staining demonstrates the location and normal morphology of cranial nerves (V, 
trigeminal; IX, glossopharyngeal). Scale bar: 500 µm. (B) Cytochrome oxidase staining in 
spinal trigeminal nucleus reveals normal formation of whisker-related barrelettes in newborn 
DPP9ki/ki mice. Scale bar: 100 µm (C) Brainstem motor neurons develop normally in DPP9ki/ki 
newborn mice as shown on representative images and quantitative analysis of motor neuron 
populations (Mo5, trigeminal motor nucleus; 7N, facial motor nucleus, 12N, hypoglossal 
motor nucleus). Scale bar: 100 µm (D, E) The morphology of neuromuscular junctions is 
grossly normal in DPP9ki/ki newborn mice as shown by immunofluorescence staining of axonal 
neurofilaments and α-BTX staining of postsynaptic nAChRs in masseter (D) and tongue (E) 
muscles. Scale bars: 50 µm 
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In contrast to the normal nipple finding and normal jaw movement, DPP9ki/ki mice 
displayed defects in nipple attachment (Figure 2.3E). DPP9ki/ki mice were unable to 
attach well to mother’s nipple and did not stretch the nipple when they were pulled 
away from the mother (Figure 2.3E and F) implicating potential craniofacial 
abnormalities as a cause of suckling defects. 
 
Microglossia with intrinsic distal tongue muscle defects in DPP9ki/ki mice 
The examination of craniofacial structures revealed reduced tongue size in newborn 
DPP9ki/ki mice as visualized macroscopically and quantified by surface area 
measurement (Figure 2.5A). H&E-stained frontal sections of P1 heads confirmed 
shorter (Figure 2.5B, level a) and smaller (Figure 2.5B, lever b) tongue in DPP9ki/ki 
mice as compared to DPP9+/+ littermates, whereas the size of other structures including 
nasal cavity was comparable between the groups (Figure 2.5B). Histological 
evaluation of the tongue revealed that longitudinal muscle fibers in distal intrinsic 
tongue muscle failed to develop in newborn DPP9ki/ki mice (Figure 2.5C). Defects 
were restricted to distal intrinsic tongue muscle since the two other types of tongue 
muscles including extrinsic and proximal intrinsic muscles formed normally in 
DPP9ki/ki mice (Figure 2.5C). Similarly, normal masseter muscle was found in 
newborn DPP9ki/ki mice (Figure 2.5B, arrow). The reduced tongue size in DPP9ki/ki 
mice was already evident at E12.5, demonstrating that DPP9 enzymatic activity is 
required for normal tongue development (Figure 2.5D). Cleft palate, the frequently 
observed craniofacial defect linked to suckling related neonatal lethality, was not 
present in DPP9ki/ki mice which displayed normal fusion of palatal shelves (Figure 
2.5B, asterisk).  
We also investigated whether DPP9+/ki mice display any craniofacial abnormalities 
knowing that in heterozygous mice 80% of DPP9 enzymatic activity is inhibited as 
demonstrated by ABP pull down of brain tissue at P1 (Figure 2.6A). The tongue size 
analysis performed in newborn and 25 weeks old DPP9+/ki mice did not reveal any 
tongue defects (Figure 2.5A and 2.6B), thus indicating that the remaining 20% of 
DPP9 enzymatic activity is sufficient for normal tongue development. To further 
exclude any potential impairments in tongue function, body weight and food intake 
were measured weekly from the age of 5 weeks until the age of 25 weeks in DPP9ki/+  
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Figure 2.5.  DPP9ki/ki mice exhibit microglossia with impaired intrinsic distal tongue 
muscle formation. 
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and DPP9+/+ mice. As shown in figure 2.6C and D, DPP9ki/+ mice were 
indistinguishable from control mice in all assessed parameters. 
 
Reduced number and impaired survival of migratory tongue muscle progenitors 
in DPP9ki/ki mice 
During the tongue development, extrinsic tongue muscles and proximal intrinsic 
tongue muscles derive from the head mesenchyme, whereas the distal intrinsic tongue 
muscles are formed mainly by migratory muscle progenitors that derive from the 
somites at occipital level (Huang et al. 1999; Vasyutina et al. 2005). Since DPP9ki/ki 
mice showed impaired formation of distal intrinsic tongue muscles, we next examined 
the migratory tongue muscle progenitors. It is well documented that muscle precursors 
at occipital, cervical and limb levels delaminate from lateral dermomyotome, a 
derivative of the somite, and actively migrate to their target sites to generate tongue, 
diaphragm, and limb muscles, respectively (Chevallier et al. 1977; Christ et al. 1977; 
Christ and Ordahl 1995). The homeobox gene Lbx1 is exclusively expressed in 
dermomyotomes of occipital, cervical and limb levels where it specifically marks 
migratory muscle precursors (Dietrich et al. 1999). We reconstructed the migration 
stream of tongue muscle progenitors in DPP9+/+ and DPP9ki/ki embryos by staining the 
consecutive E10.75 sections with Lbx1 antibody. In both, DPP9+/+ and DPP9ki/ki 
embryos, a stream of Lbx1+ muscle progenitors was observed in the hypoglossal cord 
and in the first branchial arch, which is the route and the target area of the migratory 
cells, respectively (Figure 2.7A). Quantification of Lbx1+ area revealed significantly  
(A) Reduced tongue size in DPP9ki/ki newborn mice visualized macroscopically and 
quantified by surface area measurement. Scale bar: 1 mm (B) H&E-stained frontal head 
sections show shorter (level a) and smaller (level b) tongue in DPP9ki/ki newborn mice 
compared to DPP9+/+ littermates. Formation of masseter muscle (arrow) and palate 
(asterisk) are normal in DPP9ki/ki newborn mice. Dashed lines indicate outline of the 
tongue. Scale bar upper panel: 500 µm, lower panel: 1 mm. (C) DPP9ki/ki mice lack 
longitudinal muscle fibers in intrinsic distal tongue muscle (i) whereas intrinsic proximal 
(ii) and extrinsic (iii) tongue muscles develop normally. Middle and bottom panels show 
magnified view of respective muscles. Scale bar top panel: 500 µm, middle and bottom 
panels: 100 µm. (D) In DPP9ki/ki mice, reduced tongue size is evident as early as E12.5 and 
remains through the development as shown on H&E-stained frontal head sections. Scale 
bars: 500 µm. 
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decreased number of migratory tongue muscle progenitors in DPP9ki/ki embryos 
compared to DPP9+/+ littermates (Figure 2.7A). The reduction in Lbx1+ muscle 
progenitors was accompanied by an increased spontaneous apoptosis in both the 
hypoglossal cord and the first branchial arch as shown by elevated cleaved caspase 3 
signals (Figure 2.7B). The analysis of limb muscles, known also to derive from Lbx1+ 
migratory muscle progenitors, showed comparable number of Lbx1+ cells and no 
difference in the apoptosis between DPP9ki/ki and DPP9+/+ littermates at E10.75 (Figure 
2.7C). These results demonstrate that DPP9 enzymatic activity is crucial for the 
survival of tongue muscle progenitors but has no effect on other migratory muscle 
progenitors. Analysis of DPP9 protein expression in E10.75 wild type mice revealed 
ubiquitous expression including Lbx1+ migratory tongue muscle progenitors in the 
hypoglossal cord and the first branchial arch (Figure 2.7D). Furthermore, although 
DPP9 is highly expressed at neural tube at E10.75 (Figure 2.7E), no changes were  
 
 
Figure 2.6.  Normal tongue size, food intake and body weight in DPP9+/ki mice. (A) 
reduction of DPP9 enzymatic activity is reduced by ~80% in DPP9+/ki compared to DPP9+/+ 
brains at P1 as shown by quantitative assessment of ABP assay. (B) Tongue surface area 
measurement shows similar tongue size in DPP9+/+ and DPP9+/ki mice at the age of 25 weeks. 
(C, D) Body weight evolution (C) and food intake (D) are comparable between DPP9+/+ and 
DPP9+/ki from 5 till 25 weeks of age.  
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Figure 2.7.  Migration of tongue muscle progenitors along the hypoglossal cord to first 
branchial arch is associated with reduced number of Lbx1+ progenitors and increased 
apoptosis in DPP9ki/ki embryos at E10.75. 
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observed in the number of Lbx1+ cells and/or apoptosis in neural tube from DPP9ki/ki 
mice at E10.75 (Figure 2.7F). 
CXCR4 and its ligand SDF-1, expressed in the hypoglossal cord and the first branchial 
arch, respectively, are required for migration and survival of migratory hypaxial 
muscle progenitors (Vasyutina et al. 2005). In CXCR4-deficient mice, reduced number 
of muscle progenitors at the first branchial arch and dorsal limb is observed, and it is 
accompanied by increased apoptosis (Vasyutina et al. 2005).Therefore, next we 
examined expression of CXCR4 protein in migratory muscle progenitors from 
DPP9ki/ki mice. No obvious differences were observed in CXCR4 staining in the 
hypoglossal cord and the first branchial arch in DPP9ki/ki and DPP9+/+ mice at E10.75 
(Figure 2.8A). In addition, since CXCR4 is Gi coupled receptor, we measured cAMP 
level upon SDF-1 treatment in HEK293 cells stably expressing CXCR4 transfected 
with wild type DPP9 plasmid (wtDPP9) or enzyme-inactive S729A mutant DPP9 
plasmid (mutDPP9). Increased production of cAMP by forskolin was reduced upon 
SDF-1 treatment in CXCR4 stable cell line overexpressing wtDPP9 or mutDPP9 in a 
similar extent, demonstrating that absence of DPP9 enzyme does not impair CXCR4 
signaling (Figure 2.8B). Compared to non-transfected cells, slight reduction in cAMP 
level was observed in cells overexpressing wtDPP9 plasmid upon forskolin treatment. 
This can be due to the transfection itself or an effect of DPP9 on cAMP formation 
which is independent of CXCR4 signaling. Furthermore, overexpression of enzyme 
inactive DPP9 in CXCR4 stable cell line show normal membrane localization of 
CXCR4 (Figure 2.8C). In conclusion, reduced survival of migratory tongue muscle 
(A) Reduced number of Lbx1+ muscle progenitors in the hypoglossal cord (arrow) and the first 
branchial arch (arrowhead) in DPP9ki/ki mice compared to DPP9 +/+ littermates is shown on 
representative images and by quantitative assessment of Lbx1+ area in the reconstructed 
regions of interest. Scale bar: 100 µm. (B) Increased apoptosis analyzed by cleaved caspase-3 
(CC3) in hypoglossal cord and the first branchial arch along the Lbx1+ area in DPP9ki/ki mice 
compared to DPP9+/+ littermates. Representative images and quantitative assessment of 
cleaved caspase 3+ area in both hypoglossal cord and first branchial arch are shown. Scale 
bars: 20 µm. (C) In forelimbs, comparable levels of Lbx1+ and cleaved caspase-3+ cells are 
observed in DPP9ki/ki and DPP9+/+ littermates. Scale bars: 100 µm. (D-E) Ubiquitous 
expression of DPP9 protein including Lbx1+ cells along the hypoglossal cord (D) and the 
neural tube (E) in wild-type embryos at E10.75. Scale bars D: 10 µm, E: 20 µm. (F) In the 
neural tube, comparable levels of Lbx1+ and cleaved caspase-3+ cells are observed in DPP9ki/ki 
and DPP9+/+ littermates. Scale bars: 20 µm. 
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progenitors is observed in DPP9ki/ki mice while loss of DPP9 enzymatic activity had no 
effect on other types of migratory hypaxial muscle progenitors. Furthermore, effects of 
DPP9 did not involve the modulation of CXCR4 signaling pathway. 
 
Impaired fetal hematopoiesis but functional hematopoietic cells in DPP9ki/ki mice  
Human and rodent leukocytes and immune organs express DPP9 and have DPP8/9 
activity as published (Ajami et al. 2004; Maes et al. 2007; Yu et al. 2009; Chowdhury 
et al. 2013) and shown by our study (Figure 2.9A and B). Furthermore, DPP9 is shown 
to regulate immune function in vitro and in vivo (Lankas et al. 2005; Reinhold et al. 
2009). In order to investigate the role of DPP9 in the immune system, we characterized 
the immune-related phenotype of DPP9ki/ki mice. Peripheral blood analysis of newborn 
 
 
Figure 2.8.  Normal CXCR4 signaling in the absence of DPP9 enzymatic activity. (A) 
Comparable distribution of CXCR4 protein in Lbx1+ cells in hypoglossal cord from 
DPP9ki/ki and DPP9+/+ littermates at E10.75. Scale bars: 20 µm. (B) Inactivation of DPP9 
enzymatic activity does not alter CXCR4-mediated Gi signaling upon hSDF-1α treatment. 
Similar level of cAMP reduction upon SDF-1α treatment is observed in CXCR4 stable cell line 
transfected with wtDPP9 plasmid or mutDPP9 plasmid. Forskolin is applied to increase cAMP 
formation and pertussis toxin to reverse Gi-coupled signaling. DPM, disintegrations per minute. 
(C) Similar distribution of CXCR4 in CXCR4 stable cell line transfected with either wtDPP9 or 
mutDPP9 plasmid. Scale bar: 5 µm. 
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DPP9ki/ki mice showed reduced number of lymphocytes and monocytes compared to 
DPP9+/+ littermates, whereas another cell types including erythrocytes or granulocytes 
were not changed (Figure 2.10A and data not shown). Next, since i) liver is the 
primary hematopoietic organ from E11 until the first postnatal week and ii) DPP9 
mRNA is expressed in newborn mouse liver hematopoietic cells (Figure 2.9C), we 
analyzed livers of E17.5 embryos by flow cytometry. Number of B220+CD43+ pro-B 
cells, CD18+CD11b+ and Gr-1+CD11b+ myeloid cells were reduced in DPP9ki/ki fetal 
livers compared to DPP9+/+ fetal livers (Figure 2.10B). These data demonstrate 
hematopoiesis defects in DPP9ki/ki mice during the development.  
Reconstitution of lethally irradiated mice with fetal liver cells is useful to study the 
hematopoiesis of neonatal lethal animals (Eckardt and McLaughlin 2008). To further 
investigate the role of DPP9 enzyme in hematopoiesis, we have reconstituted lethally 
irradiated wild-type mice with DPP9+/+ or DPP9ki/ki fetal liver cells. DPP9ki/ki fetal liver 
cells successfully reconstituted immune system of recipients as DPP9+/+ fetal liver cells 
(data not shown). To avoid potential compensation of DPP8 enzyme, highly 
homologous with DPP9 and expressed in immune cells (Figure 2.9A), we performed 
competitive reconstitution assay. Fetal liver cells from E17.5 DPP9+/+ and DPP9ki/ki 
embryos (CD45.2) were injected into lethally irradiated wild-type recipient mice 
(CD45.1) together with an equal number of competitor fetal liver cells from wild-type 
E17.5 embryos (CD45.1) (Figure 2.10C). Cells from bone marrow, spleen and thymus 
of recipient mice were analyzed by flow cytometry 6 weeks after the reconstitution. As 
shown in figure 2.10D, DPP9ki/ki CD45.2+ cells were detected in bone marrow, spleen 
and thymus of recipients with similar frequency as DPP9+/+ CD45.2+ cells. Further 
staining with surface markers revealed that contribution of DPP9ki/ki CD45.2+ fetal 
liver cells to reconstitution of subpopulation of immune cells in recipient mice is 
comparable to that of DPP9+/+ CD45.2+ fetal liver cells, implying the full potential of 
DPP9ki/ki fetal liver cells to differentiate into lymphoid and myeloid lineages (Figure 
2.10E). In summary, these data demonstrate impaired hematopoiesis in DPP9ki/ki mice 
but normal ability of DPP9ki/ki hematopoietic stem cells to reconstitute functional 
immune system. Thus providing the evidence that DPP9 enzymatic activity in 
hematopoietic stem cells is not essential for normal hematopoiesis in mice. 
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Figure 2.9.  DPP9 is expressed in human blood immune cells and mouse liver 
hematopoietic cells. (A) Expression of DPP9 and DPP8 mRNA in subsets of purified human 
immune cells determined by Real-time PCR. (B) Immunohistochemical analysis of DPP9 
expression in purified human CD45+ leukocytes. Scale bar: 20 µm. (C) DPP9 is expressed in 
mouse liver hematopoietc cells at P1 as shown by in situ hybridization (upper panel) and 
immunohistochemistry (lower panel). Scale bars: 10 µm. 
 44 
 
Figure 2.10.  Defects in fetal hematopoiesis in DPP9ki/ki mice but normal development of 
DPP9ki/ki hematopoietic stem cells in competitive mixed chimeras. (A) Reduced number of 
blood lymphocytes and monocytes in newborn DPP9ki/ki mice. (B) Decreased number of Pro-
B cells (B220+CD43+), CD18+CD11b+ and Gr-1+CD11b+ myeloid cells in the liver of 
DPP9ki/ki mice at E17.5 by FACS analysis. (C) Competitive reconstitution assay. Lethally 
irradiated CD45.1+ recipient mice were reconstituted with either CD45.2+ DPP9ki/ki or 
CD45.2+ DPP9+/+ fetal livers, each mixed at 1:1 ratio with CD45.1+ wild-type fetal livers. (D) 
Representative FACS analysis of recipient bone marrow, spleen and thymus at 6 weeks after 
reconstitution show similar contribution of DPP9ki/ki and DPP9+/+ donor cells to the 
reconstituted hematopoietic system. Numbers indicate relative percentage of cells gated on 
CD45.1 or CD45.2. (E) DPP9ki/ki and DPP9+/+ fetal liver cells are able to reconstitute the bone 
marrow, spleen and thymus of mixed chimeras to a similar extend as shown by subsets of 
myeloid and lymphoid immune cells. SP, single positive; DP, double positive. 
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2.3 Discussion 
DPP9 enzymatic activity controls survival of tongue muscle progenitors and its 
absence results in impaired tongue development, suckling defect, and neonatal 
lethality in mice. 
Catalytically inactive DPP9 knock-in mice are neonatally lethal indicating that DPP9 
enzymatic activity is essential for mouse survival (Gall et al. 2013). Despite this, the 
primary physiological defects responsible for their lethality and the biological function 
of DPP9 enzymatic activity remain unknown. In this study we analyzed the neonatal 
lethal phenotype of DPP9ki/ki mice generated by serine to alanine point mutation 
(S729A) in the catalytic domain of DPP9 gene, an approach identical to the one used 
by Gall and colleagues (Gall et al. 2013). We could show that DPP9ki/ki mice survive 
birth but die within 12 to 18 h after birth. The fact that DPP9ki/ki mice do not die 
immediately after birth together with their normal breathing and normal lung 
development allowed us to exclude respiratory failure as cause of their neonatal 
lethality. Instead, we found that DPP9ki/ki mice lack milk in the stomach a few hours 
after birth indicating abnormal feeding as the primary cause their death. Interestingly, a 
number of neonatal lethal mutant mice non-feeding or fasting newborns die within a 
window of 12-24 h after birth which is when also DPP9ki/ki mice die as shown by a 
precise identification of the timing of their death. 
Complete inability of mice to feed can lead to neonatal death due to the absence of 
nourishment and mice survival can be rescued by manual feeding. In agreement with 
this, feeding of newborn DPP9ki/ki with cat milk rescued their survival during the entire 
course of the study thus confirming that feeding defects are the primary cause of their 
death. Video recording of dams during and after the birth revealed normal nursing by 
mother. Furthermore, normal fasting glucose levels in DPP9ki/ki mice exclude potential 
homeostasis defaults. 
Defects in neuromuscular system, olfactory or sensory-motor neuronal pathways can 
also impair suckling and challenge neonatal survival (Turgeon and Meloche 2009), 
however, our analysis did not reveal any overt differences in DPP9ki/ki mice. Instead, 
we show that DPP9ki/ki mice have craniofacial defects characterized by reduced tongue 
size. Tongue, together with the lips and gums, form a seal against the mother’s nipple 
and generate negative pressure to maintain nipple within the mouth and to stimulate 
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milk ejection (Ardran et al. 1958; Woolridge 1986). In agreement with this, DPP9ki/ki 
mice fail to attach well to mothers nipples as shown by video recording of their feeding 
behavior. Smaller tongue in DPP9ki/ki mice is accompanied by impaired formation of 
intrinsic distal tongue muscle but normal development of intrinsic proximal and 
extrinsic tongue muscles. Interestingly, the origin of tongue musculature differs 
depending of the type of muscle. The intrinsic distal tongue muscle is formed mainly 
by somatic-derived long-range migrating progenitor cells while intrinsic proximal and 
extrinsic tongue muscles derive from the head mesenchyme (Huang et al. 1999; 
Vasyutina et al. 2005). In accordance with the defect in intrinsic distal tongue muscle, 
DPP9ki/ki mice exhibited reduced number and survival of muscle progenitors deriving 
from occipital somites and forming distal components of the intrinsic tongue muscle. 
In contrast, the muscles known to derive from head mesenchyme including intrinsic 
proximal and extrinsic tongue muscles and masseter muscle developed normally in 
DPP9ki/ki mice. Similar tongue phenotype is observed in mice lacking genes crucial for 
migration of muscle progenitors. These include knockout mice of c-Met, scatter 
factor/hepatocyte growth factor (SF/HGF), Lbx1, Gab1 or CXCR4/Gab1 (Bladt et al. 
1995; Dietrich et al. 1999; Brohmann et al. 2000; Sachs et al. 2000; Vasyutina et al. 
2005). However, these knockout mice display broad defects in other hypaxial muscles 
deriving from migrating progenitors, such as limb or diaphragm muscles, which is not 
the case of DPP9ki/ki mice. Quantitative analysis of Lbx1 positive migratory muscle 
progenitors giving rise to limb muscle did not reveal any alterations in DPP9ki/ki mice. 
Furthermore, limb and diaphragm muscles were functional as demonstrated by normal 
movement and respiration of newborn DPP9ki/ki mice. One possible explanation for the 
tongue specific phenotype could be differences in the expression level of DPP9 
enzyme or its substrate in muscle progenitors originating from occipital, cervical or 
limb somites. Alternatively, there might be distinct cues or survival factors which, 
when encountered by migratory muscle progenitors, differentially regulate their 
survival depending on the subpopulation of migrating muscle progenitors. This 
hypothesis is supported by phenotype of Lbx1 knock-out mice where not all migrating 
muscle progenitors are equally affected despite Lbx1 being expressed in all migrating 
hypaxial muscle progenitors (Brohmann et al. 2000; Gross et al. 2000).  
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Despite high homology and similar substrate specificity between DPP8 and DPP9, 
functional differences emerged in a number of studies between those enzymes (Geiss-
Friedlander et al. 2009; Yao et al. 2011; Matheeussen et al. 2013). Here we show a 
unique role of DPP9 enzyme in the survival of migratory tongue muscle progenitors 
which is not compensated by DPP8 activity. Molecular mechanisms of how DPP9 
enzymatic activity regulates apoptosis of tongue muscle progenitors remain largely 
unknown. A possible hypothesis is that DPP9 enzymatic activity regulates CXCR4-
SDF-1 signaling in migrating tongue muscle progenitors. CXCR4-SDF-1 axis is 
important for the survival and migration of muscle progenitors (Vasyutina et al. 2005), 
with CXCR4 and SDF-1 being expressed by migratory muscle progenitors and their 
target area, respectively (Vasyutina et al. 2005). Our study excluded the possibility that 
DPP9 impairs migration and survival of tongue muscle progenitors by regulating 
CXCR4 signaling. First of all, no differences were observed in CXCR4 protein levels 
in Lbx1+ tongue muscle progenitors in DPP9ki/ki embryos. Secondary, loss of mouse 
DPP9 enzymatic activity in HEK293 cells did not affect membrane localization of 
CXCR4 and CXCR4 signaling thus suggesting normal CXCR4 signaling in the 
absence of DPP9 enzymatic activity. At this stage we cannot exclude that DPP9 
enzymatic activity regulates receptor binding and/or functional activity of SDF-1 by 
proteolytic cleavage. The N-terminal region of SDF-1 is critical for CXCR4 activation 
and function and the truncation of this region by DPPIV to form processed/truncated 
SDF-l (i.e., SDF-l3–68) inhibits the chemotactic properties of the cell and CXCR4 
signaling (Shioda et al. 1998; McQuibban et al. 2001). DPP8 shares similar substrate 
specificity with DPPIV and can cleave SDF-1 in vitro (Ajami et al. 2008). Processing 
of SDF-1 by DPP9 is not reported so far. Mass spectrometry could be applied to test 
processing of SDF-1 by DPP9 in vitro. Furthermore, in situ mass spectrometry could 
be used to analyze the full-length vs cleaved SDF-1 levels ex vivo in the first branchial 
arch from DPP9+/+ and DPP9ki/ki embryos. It remains to be investigated whether DPP9 
by processing SDF-1 regulates the survival of tongue muscle progenitors during mouse 
development. 
An alternative hypothesis is that DPP9 enzyme modulates activity of proteins involved 
in apoptosis pathway. In vitro studies suggest the role of DPP9 enzyme in regulation of 
apoptosis which is cell-type or disease dependent. In line with our study, DPP8/9 
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inhibition results in increased spontaneous apoptosis in macrophages derived from 
human primary monocytes or human monocytic cell line although the underlying 
mechanism is not identified (Matheeussen et al. 2013). Further evidence comes from 
siRNA-mediated DPP9 knock down in Ewing Sarcoma tumor cell where an increased 
apoptosis is reported (Lu et al. 2011). This process is shown to be mediated by 
activation of Y1 receptor by full-length NPY1-36 and can be inhibited by enzymatically 
active DPP9. An independent group also reported processing of NPY by DPP9 in vitro 
(Bjelke et al. 2006). Therefore, DPP9 enzymatic activity could control the survival of 
migratory tongue muscle progenitors by cleaving NPY1-36 to NPY3-36, and preventing 
the activation of Y1 receptor. Further investigations are required to validate this 
hypothesis since at the moment no data are available on expression of NPY or its 
receptors in migratory tongue muscle progenitors in mice. 
The phenotype of DPP9ki/ki mice is similar to mice lacking c-Met or HGF/SF thus, 
suggesting a role for DPP9 in modulating c-Met signaling pathway. It is rather unlikely 
that c-Met or SF/HGF themselves are direct targets of DPP9. Muscle progenitors of c-
Met-/- or SF/HGF-/- mice do not delaminate from the somites (Dietrich et al. 1999) 
whereas muscle progenitors in DPP9ki/ki mice are released and migrate towards the first 
branchial arch. However, mice deficient in Gab1, an important adaptor molecule of c-
Met signal transduction, exhibit small tongue with reduced number of muscle 
progenitors accompanied by increased apoptosis similar to DPP9ki/ki mice (Sachs et al. 
2000; Vasyutina et al. 2005). Thus, it is possible that DPP9 regulates Gab1 or related 
adaptor protein of a c-Met pathway. The identification of in vivo substrates of DPP9 
will help to understand the mechanisms underlying the developmental defects in 
migratory tongue muscle progenitors in DPP9ki/ki mice. 
 
DPP9 enzymatic activity in fetal hematopoietic stem cells is dispensable for 
normal hematopoiesis 
We studied the immune-related phenotype of DPP9ki/ki mice because of i) DPP9 
protein and mRNA expression and the reported DPP8/9 enzymatic activity in the 
immune cells (Ajami et al. 2004; Maes et al. 2007; Yu et al. 2009; Chowdhury et al. 
2013) and this study, ii) the immunosuppressive activity of DPP8/9 dual inhibitor in in 
vitro studies (Lankas et al. 2005; Reinhold et al. 2009) and iii) controversial data on 
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the immune-related toxicity of DPP8/9 dual inhibitors (Lankas et al. 2005; Wu et al. 
2009). Furthermore, pharmacological studies with DPP8/9 dual inhibitors could not 
address the respective contribution of DPP8 and DPP9 inhibition to in vivo toxicity. 
Thus, DPP9ki/ki mice enabled us to mimic the effect of a selective DPP9 inhibitor 
which is not yet available. DPP9ki/ki mice showed reduced number of lymphoid and 
myeloid cells in fetal liver and postnatal blood. However, their hematopoietic stem 
cells were fully competent in reconstituting the immune system of lethally irradiated 
recipients, implying a dispensable role of DPP9 enzyme in normal hematopoiesis. We 
cannot rule out DPP9 enzymatic activity in non-hematopoietic cells which might 
regulate hematopoiesis and notably, this might be the cause of the hematopoiesis 
defect shown in DPP9ki/ki mice. Reconstitution of lethally irradiated conditional DPP9 
enzyme-inactive mice with wild-type fetal liver cells could be applied to elucidate the 
role of non-hematopoietic cell-derived DPP9 activity in hematopoiesis. Furthermore, 
although DPP9 enzyme is not essential for normal hematopoiesis we cannot exclude 
the role of DPP9 enzyme under certain circumstances, for example, in the presence of 
antigens or in a disease setting. Thus, further investigation is required to clarify the 
contribution of DPP9 activity in hematopoiesis and immune responses under diverse 
physiological conditions.  
 
2.4 Conclusions 
Dipeptidyl peptidase 9 (DPP9), an intracellular N-terminal post-proline-cleaving 
enzyme, is implicated in cell behavior and immune responses but its physiological 
function remains largely unknown. Here we investigated in vivo role of DPP9 enzyme 
by characterizing DPP9 knock-in mice expressing a catalytically inactive S729A 
mutant of DPP9 (DPP9ki/ki mice). We show that impaired suckling response is a 
primary cause of perinatal lethality of DPP9ki/ki mice which die within 12-18 h after 
birth and can be rescued by manual feeding. Suckling defect is a result of microglossia 
characterized by defects in the formation of intrinsic distal tongue muscle known to 
derive from migratory muscle progenitors while intrinsic proximal and extrinsic 
tongue muscles deriving from head mesenchyme develop normally in DPP9ki/ki mice. 
Smaller tongue size of DPP9ki/ki mice correlates with reduced number and impaired 
 50 
survival of migratory tongue muscle progenitors. CXCR4 mediated survival and 
migration of muscle progenitors is not impaired in the absence of DPP9 enzymatic 
activity however, an effect of DPP9 enzyme on SDF-1, ligand of CXCR4, cannot be 
excluded. In addition, we show that DPP9ki/ki mice exhibit impaired fetal 
hematopoiesis however their hematopoietic stem cells are fully competent in 
reconstitution of myeloid and lymphoid lineages in lethally irradiated mice. Taken 
together, our studies revealed for the first time that DPP9 enzyme controls survival of 
migratory tongue muscle progenitors and its absence in mice leads to impaired tongue 
development, suckling defect and neonatal lethality but DPP9 enzymatic activity in 
hematopoietic cells is dispensable for normal hematopoiesis. 
 
2.5 Materials and methods 
Generation of DPP9 and DPP8 knock-in mice  
Mice with a targeted DPP9 locus were generated by homologous recombination in ES 
cells. The targeting vector was constructed using C57BL/6 mouse genomic DNA. The 
TCC  GCC mutation in nucleotide 97 – 99 of exon 18 of the DPP9 gene (NCBI 
Reference Sequence: NM_172624.3) was introduced by overlapping polymerase chain 
reaction. Mutated exon 18 was subcloned in multiple cloning site of pRay-MCS1-2lox-
2frt vector, surrounded by two LoxP sites. As long homology arm, a 4 kb 5’ fragment 
encompassing end of intron 15, exons 16 and 17 was amplified and further cloned 
upstream of the 5’ LoxP site. Short homology arm, a 1.9 kb 3’ fragment containing 
introns 19 and 20 was amplified and subcloned down stream of second FRT site in 
cloning vector. The DPP9 targeting vector contained a neomycin resistance gene 
(neoR) flanked by two FRT sites. NotI linearized targeting vector was electroporated 
into C57BL/6 ES cells. Neomycin resistant clones were isolated and analyzed for 
homologous recombination by nested PCR using the primer pairs 
TCCTCGTGCTTTACGGTA – TGCCTGCTATAAATCCATC and 
CTATCGCCTTCTTGACGA – CCACCCAAACCTCAGGTC. For Southern blot, 4 
µg of genomic DNA was digested with 25 units of Sac I, separated on a 0.8% agarose 
gel followed by vacuum blotting with 20× SSC on nylon membrane. Hybridization 
with the 32P ([α32P]dCTP, Hartmann Analytic)-labeled DNA probe (Rediprime II, GE 
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Healthcare) was performed in Perfect Plus Hybridization buffer (Sigma) at 65°C 
overnight followed by image analysis using a FLA-5000 imaging system (Fujifilm). 
Targeted C57BL/6 ES clones were injected into Balb/C host blastocysts and 
transferred into pseudopregnant CB6F1 foster mothers. Male chimeric mice were 
crossed with wild type C57BL/6 mice to produce F1 animals. Black offspring 
indicated the germline transmission of the targeted ES cells. Males carrying modified 
DPP9 gene were mated with female mice expressing the Flp recombinase to remove 
the neomycin resistance cassette. The Flp recombinase was removed in a subsequent 
breeding step with wild-type mice. DPP9 knock-in heterozygous (DPP9ki/+) mice were 
mated to obtain DPP9 knock-in homozygous (DPP9ki/ki) mice. Genotyping was 
performed by PCR on tail DNA using the following primers: 
TATGATGGCAGTGATGATC and CTTAGACGCCAAGTAGTATTTA, with 
expected bands sizes of 143 bp for wild-type and 191 bp for transgenic allele. DPP8 
knock-in mice were generated using similar strategy with a S749A mutation in DPP8 
protein. 
Synthesis of fluorphosphonate (FP)-biotin 
Bionylated PEG linker azide and biotin-PEG(3+4)-N3 were purchased from Iris 
Biotech GmbH and all other reagents and solvents were purchased from Sigma. An 
FP-alkyne intermediate was synthesized as described previously (Gillet et al. 2008) 
and fused to biotin-PEG(3+4)-N3 by a copper catalyzed cycloaddition (also referred to 
as click-chemistry) to obtain the FP-biotin. A solution of FP-alkyne intermediate 
(0.075 mmol) in DMSO (750 µl) in 10 ml round bottom flask was added a solution of 
biotin-PEG(3+4)-N3 (36 mg, 0.050 mmol) in DMSO (500 µl). Separately, copper (I) 
bromide (7.17 mg, 0.050 mmol) was dissolved in MeCN (722 µl) and added to Tris[(1-
benzyl-1H-1, 2, 3-triazol-4-yl)methyl]amine (26.5 mg, 0.050 mmol). The resulting 
clear solution was introduced to the substrate solution above. The reaction was swirled 
at 23°C for 16 h. MeCN was evaporated, and the residue was diluted with TBME (10 
ml). The resulting suspension was centrifuged and the precipitate was washed with 
TBME, suspended in MeCN, centrifuged, and the supernatant was collected. This step 
was repeated and the combined MeCN supernatant was evaporated. The residue was 
taken up in water (ca. 10 ml) and extracted with dichloromethane (10 ml × 5). The 
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combined dichloromethane phase was dried over Na2SO4, filtered and evaporated. The 
residue was again taken up in water (10 ml), which was washed with EtOAc (10 ml × 
2), then extracted with dichloromethane (10 ml × 5). The combined dichloromethane 
phase was dried over Na2SO4, filtered, evaporated to give FP-biotin (15.1 mg, 0.014 
mmol, 28.6 % yield) as a yellow film. 1H-NMR: (400MHz, d6-DMSO) δ-NMP: 
(400MHζ, UPLC-MS: Acquity HSS T3 1.8 µm 2.1 × 50 mm at 50°C, solvents A1 = 
water + 0.1 % HCOOH, B1 = MeCN + 0.1 % HCOOH, 5 -> 90 % B1 in 2.5 min, Rt = 
0.62 min, SQ pos [M+H+] 1003.04, [M+Na+] 1025.03, SQ neg [M+HCOO-] 1047.13 
H-NMR: d6-DMSO, consistent with the expected structure. 
Recombinant protein expression and purification 
Full-length human DPP8 cDNA was subcloned into pFastBac1 vector (Life 
Technologies) with His and V5 tag and expressed in insect Sf9 cells using the Bac-to-
Bac baclovirus expression system (Life Technologies) followed by affinity purification 
with His tag using Talon Cellthru metal affinity column (Clontech). Full-length human 
DPP9 and PEP cDNA were subcloned into pPICZα-His vector (Life technologies) 
with His tag and expressed in Pichia pastoris X-33 cells (Life technologies) followed 
by affinity purification with His tag using Ni-NTA beads (Qiagen). 
Activity-based probe (ABP) pull down assay 
Half of the snap frozen brain (~50 mg) from new born mice was homogenized in 300 
µl of Lysis buffer (100 mM Tris-HCl pH 7.3, 100 mM NaCl, 5% glycerol, 1.5 mM 
MgCl2, 1 mM DTT and 0.8% NP-40) containing 250U Benzonase (Sigma) with 
matrix D beads using FastPrep-24 (MP Biomedicals). Lysates were centrifuged at 
14,000 rpm, 4°C for 20 min and 2 mg of lysates or 30 nM of human DPP8 and DPP9 
recombinant proteins were incubated with 10 µM of FP-biotin for 1 h at RT. Reaction 
was quenched with 0.25% SDS and samples were diluted to 1 ml with wash buffer 
(100 mM Tris-HCl pH 7.3, 100 mM NaCl, 5% glycerol, 1.5 mM MgCl2, 1 mM DTT 
and 0.25% SDS) followed by incubation with 200 µl of high capacity streptavidin 
beads (Thermo Sci.) for 1 h at RT. Samples were centrifuged at 300 × g for 5 min to 
remove supernatant and washed twice by gravity flow. Proteins bound to FP-biotin 
were eluted with elution buffer (100 mM phosphate buffer pH 10.2, 2.8% SDS, 18% 
glycerol, 160 mM DTT, 30 mM biotin, 0.02% Bromophenol blue) at 90°C for 10 min 
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at 700 rpm Thermomixer (Eppendorf). Eluted fractions and human DPP9, DPP8 and 
PEP recombinant proteins were loaded on 4-12% Bis/Tris gel (Life Technologies) and 
western blot was performed using rabbit anti-DPP8, DPP9 and PEP antibodies (all 
from Abcam). 
Transfection 
Plasmids containing the full-length of mouse DPP9 and DPP8 cDNA were purchased 
from Biocat. Mouse CXCR4 was cloned from RAW264.7 cDNA library and 
subcloned into pcDNA3.1 vector for expression of C-terminal V5-His tagged CXCR4 
using pcDNA 3.1D TOPO expression kit (Life Technologies). Plasmid expressing 
enzyme-inactive S729A mutant of mouse DPP9 (mutDPP9) was generated using 
primers for site-directed mutagenesis. HEK293 cells were obtained from ATCC and 
grown in DMEM supplemented with 10% fetal calf serum, 1 mM sodium pyruvate, 1 
mM L-glutamine and 1% penicillin/streptomycin. For the transient transfection, 
HEK293 cells were transfected with 3 µg of DPP8 or DPP9 plasmids using 
XtremeGene (Roche) according to manufacturer’s instructions. To generate HEK293 
cells stably expressing CXCR4 with a C-terminal V5-His tag (CXCR4 stable cell line), 
cells were transfected with 1 µg of plasmids using XtremeGene (Roche) according to 
manufacturer’s instructions and selected for G418 resistance. Positive clones were 
selected on the basis of V5 epitope expression using confocal microscopy. Cells were 
further transiently transfected with mouse wile-type DPP9 plasmid or mutDPP9 
plasmid. 
In situ hybridization 
Decapitated newborn mice and E10.75 embryos were fixed in 10% buffered formalin 
for 48 h or 24 h, respectively at RT. Transfected HEK293 cells were fixed in 10% 
buffered formalin overnight at 4°C. Tissues and cell pellets were processed for 
embedding in paraffin using standard procedures. 3 µm sections were deparaffinized in 
xylene and rehydrated through graded ethanol series. RNAscope 2.0 HD RED kit and 
probes (Advanced Cell Diagnostics) were used according to the manufacturer’s 
instructions with DapB as a negative control. Digital images were obtained with a 
ScanScope XT system (Leica).  
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Histology, immunohistochemistry and quantitative image analysis 
Hematoxylin and eosin (H&E) staining 
Decapitated newborn mice, embryos (E12.5-18.5) or organs (P1 brains) were fixed in 
10% buffered formalin for 48 h at RT and embedded in paraffin using standard 
procedures. 3 µm sections were deparaffinized in xylene and rehydrated through 
graded ethanol series. Sections were stained with H&E using standard protocol.  
Chromogenic DPP9 staining: 
Decapitated newborn mice were fixed in 10% buffered formalin for 48 h at RT. 
Transfected HEK293 cells and human blood CD45+ cells were fixed in 10% buffered 
formalin for overnight at 4°C. Tissues and cell pellets were processed for embedding 
in paraffin using standard procedures. 3 µm sections were deparaffinized in xylene and 
rehydrated through graded ethanol series. Endogenous peroxidase activity was 
quenched and sections were incubated with rabbit anti-DPP9 antibody (Abcam) 
followed by chromogenic detection with Histofine Simple Stain system (Nichirai 
Biosciences) and DAB (Sigma). Normal rabbit IgG (Cell Signaling) was used as a 
negative control. Digital images were obtained with a ScanScope XT system (Leica).  
Immunofluorescence staining:  
E10.75 embryos were fixed with 4% paraformaldehyde in PBS for 2 h, cryopreserved 
in 30% sucrose overnight at 4°C, and OCT embedded. 12 µm-consecutive sections 
were collected throughout the hypoglossal cord and forelimb. The following antibodies 
were used: guinea pig anti-mouse Lbx1 (Muller et al. 2002); rabbit anti-cleaved 
caspase3 (Cell Signaling); rabbit anti-CXCR4 (Abcam); rabbit anti-DPP9 (Abcam) 
and secondary antibodies conjugated with Alexa Fluor 488 or 594 (Life Technologies). 
CXCR4 was visualized by Cy3-TSA Fluorescence System (PerkinElmer Life 
Sciences). Lbx1+ or cleaved caspase 3+ area was reconstructed in consecutive sections 
from hypoglossal cord and analyzed as % of wild type littermate signal. Lbx1+ or 
cleaved caspase 3+ area was quantified in 4 representative sections from forelimb of 
each embryo and analyzed as % of wild type littermate signal. For 
immunocytochemistry, transfected CXCR4 stable cell line was fixed with 4% 
paraformaldehyde in PBS for 10 min, permeabilized with 0.25% Triton X-100 in PBS 
for 5 min and blocked with 10% horse serum in PBS for 1 h at RT. Cells were 
incubated with rabbit anti-DPP9 antibody (Abcam) and mouse anti-V5 antibody (Life 
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Technologies) for 2 h and secondary antibodies conjugated with Alexa Fluor 488 or 
594 (Life Technologies) for 1 h at RT. LSM700 confocal microscope (Zeiss), Axio 
Observer Z1 microscope (Zeiss) and AxioVision software (Zeiss) were used for image 
analysis. n=3 to 7 per group.  
Whole mount neurofilament staining: 
E10.5 embryos were fixed in 4% paraformaldehyde overnight at 4°C. Endogenous 
peroxidase was blocked by incubating the embryos overnight at 4°C in wash buffer 
(1% Triton X-100 and 10% fetal calf serum in PBS) containing 0.1% hydrogen 
peroxide. Embryos were washed 3 times for 60 min in wash buffer and incubated with 
anti-neurofilament antibody (2H3, Developmental Studies Hybridoma Bank) diluted 
1:1 in wash buffer for 3 days at 4°C. Embryos were washed 3 times for 60 min in wash 
buffer and incubated with peroxidase-conjugated goat anti-mouse IgG (Jackson 
ImmunoResearch) diluted 1:100 in wash buffer for overnight at 4°C. Embryos were 
incubated in 0.7 mg/ml DAB (Sigma) in PBS twice for 10 min and the peroxidase 
reaction was visualized by addition of hydrogen peroxide (Sigma) to 0.02%. When the 
nerves were visible (~5 min), reaction was stopped by rinsing the embryos in PBS. 
Embryos were photographed on Z16 Apo A macroscope (Leica). n=7 per group. 
Cytochrome oxidase staining: 
Newborn mice were perfused with 4% paraformaldehyde in PBS. Brains were 
dissected and post-fixed overnight at 4°C with 4% paraformaldehyde in PBS. Agarose-
embedded brains were cut into 70 µm sections with Vibratome (Leica). Sections were 
incubated in a solution containing 2.4 g of sucrose, 24 mg of cytochrome oxidase 
(Sigma) and 20 mg of DAB (Sigma) in 30 ml of PBS at 37°C in the dark until a golden 
brown staining was observed, followed by incubation in 100% ethanol and mounting 
onto slide with Aqua-Poly/Mount (Polysciences). Digital images were obtained with 
Axio Observer Z1 microscope (Zeiss) n=4 per group. 
Motor neuron analysis: 
Trigeminal, facial or hypoglossal motor nuclei were manually counted on H&E-stained 
brainstem sections from new born mice covering the largest area of respective nuclei. 
Neuromuscular junction staining: 
Masseter and tongue muscles were dissected from decapitated newborn mice, fixed 
with 1% paraformaldehyde in PBS for 10 min at RT, and teased into bundles. Bundles 
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were permeabilized with 1% Triton X-100 in PBS for 10 min, incubated with 0.1M 
glycine in PBS, and blocked with blocking buffer (0.1% Triton X-100 and 1% BSA in 
PBS) for 30 min. Bundles were incubated with rabbit anti-neurofilament antibody 
(Sigma) in blocking buffer for overnight at 4°C, washed three times for 60 min in 1% 
BSA in PBS, and incubated with α-BTX conjugated with Alexa 488 (Life 
Technologies) and Alexa 594 conjugated chicken anti-rabbit IgG (Life Technologies) 
for 45 min in 1% BSA in PBS. Bundles were washed with 1% BSA in PBS for 2 h, 
rinsed with PBS, mounted onto slides with FluorSave (Millipore), and imaged with 
LSM700 confocal microscope (Zeiss). n=3 to5 per group. 
Manual feeding 
Newborn mice were fed with babycat milk (protein 33%, fat 39%; Royal Canin) 
dissolved at 1:6 in water (36°C) (Kutsuwada et al. 1996). Mice, separated from mother 
after birth and kept in moist chamber (Scantainer) at 33~34°C, were grasped by the 
skin on the back of the neck, and fed with milk slowly dosed into their oral cavity 
(Butchbach et al. 2007). 5 µl of milk was given every 2 h for 24 h and the surviving 
pups were euthanized at the end of the experiment. 
Suckling behavior 
Suckling behavior assay was adapted from previous study (Liu et al. 2015). Mother 
mouse was anesthetized and placed on warm pad (33~34°C). Pups were supported 5 
mm from mother’s nipple for 2 min with unrestricted movement to the nipple. Nipple 
localization, rhythmic jaw movement and nipple’s attachment were assessed twice. 
The trail was regarded as ‘succeed’ when the pup accomplished it at least once, and 
counted as ‘fail’ when the pup failed twice. 
Blood glucose measurement 
Newborn mice were separated from mother after birth and kept in moist chamber 
(Scantainer) for 3 h. Pups were sacrificed by decapitation and blood glucose levels 
were measured using an Accu-Chek glucometer (Roche). 
Body weight and food intake measurement 
Mice were housed individually and their the body weight and food consumption was 
monitored weekly, starting at the age of 5 weeks and continuing until the age of 25 
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weeks. All measurements were taken at the same time in the morning. n=16 to 19 per 
group. 
cAMP radiometric assay 
Untransfected or transfected CXCR4 stable cell line were grown as confluent 
monolayers in 48-well tissue culture dishes and incubated with [3H]adenine 
(Amersham, 100 MBq/ml) and/or pertussis toxin (PTX, Sigma, final concentration 0.4 
μg/ml) for 4 h in serum-free DMEM supplemented with 1% penicillin/streptomycin. 
After removing of the medium, cells were washed with Assay medium [20mM HEPES 
(Life Technologies) and 1g/L fatty acid free BSA (Calbiochem) in HBSS (Life 
Technologies)], and subsequently supplemented with 100 μl of Assay medium 
containing 1 mM IBMX (Fluka) to block phosphodiesterases. Into the appropriate 
wells, forskolin (Sigma, final concentration 40 μM) and/or human recombinant SDF-
1α (R&D Systems, final concentration 50 ng/ml) was added. After the 20 min 
incubation at 37°C, the medium was replaced by 100 μl of ice-cold 5% trichloroacetic 
acid (TCA; Fluka), supplemented with 100 μl of ice-cold carrier solution containing 
0.1 mM ATP (Boehringer), and 0.1 mM cAMP (Boehringer) in 5% TCA. Labeled 
cAMP was separated from free adenine and ATP using a batch column 
chromatography as previously described (Salomon 1979). n=3 per group. 
Human blood immune cells analysis 
Isolation:  
Peripheral blood was collected from healthy donors and CD4+, CD8+, CD19+, CD14+, 
CD15+, CD56+, and CD45+ cells were isolated using respective Whole Blood 
MicroBeads (Miltenyi Biotec) according to the manufacturer's instructions. 
Plasmacytoid dendritic cells (pDCs) were enriched from PBMCs by Easysep Human 
pDC Enrichment kit and Robosep instrument (Stemcell technologies) according to the 
manufacturer’s instruction. n=5 per group. 
Real time qRT-PCR: 
RNA was isolated using an RNeasy Micro kit (Qiagen) according to the 
manufacturer’s instructions. Quantitative real-time PCR was performed for DPP9 and 
DPP8 using Taqman Universal Master Mix and the ABI Prism 7900 HT Sequence 
Detection System (Applied Biosystems). n=5 per group. 
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Peripheral blood analysis 
Newborn mice were decapitated and bloods were collected in EDTA tubes. 
Differential blood counts were obtained using an automated ADVIA 2120i 
Hematology System (Siemens). 
Competitive reconstitution analysis 
E17.5 fetal liver cells (2.5 x 106 cells) from DPP9+/+ or DPP9ki/ki embryos (CD45.2) 
were mixed with the equal number of E17.5 wild-type competitor fetal liver cells 
(CD45.1) and injected intravenously into wild-type recipient mice (CD45.1) irradiated 
at a dose of 9 Gy (Gammacell 40, Best Theratronics). 6 weeks after the reconstitution, 
bone marrow cells, splenocytes and thymocytes from recipient mice were analyzed 
using flow cytometry. For contribution of DPP9+/+ fetal liver cells and DPP9ki/ki fetal 
liver cells to multilineage reconstitution of recipients, pro/pre-B cells (CD19+c-kit+), 
immature B cells (IgM+B220low), recirculating B cells (IgM+B220high) and Gr-
1+CD11b+ cells in bone marrow; IgM+ B cells (IgM+B220+), marginal zone B cells 
(CD19+CD21high), follicular B cells (CD19+CD21+CD23high), mature B cells 
(CD19+CD93-), CD8 T cells (TCR+CD8+) and CD4 T cells (TCR+CD4+) in spleen; 
CD8 SP cells (CD4-CD8+), CD4 SP cells (CD4+CD8-) and CD4 CD8 DP cells 
(CD4+CD8+) in thymus were analyzed for CD45.1 or CD45.2. The % CD45.2+ cells/% 
CD45.1+ cells ratio was calculated for each subpopulation of cells in individual 
animals. This value was divided by the % CD45.2+ cells/% CD45.1+ cells ratio of total 
cells in the organ of individual animals to account for the variation of reconstitution 
efficiency in each animal. n=3 per group. 
Flow cytometry 
Single-cell suspensions of bone marrow, spleen, thymus, and liver were prepared by 
mechanical disruption, stained with appropriate reagents, and analyzed using a 
FACSCalibur (Becton Dickinson) or CyAn ADP 9 color Analyzer (Beckman Coulter) 
and FlowJo software (FlowJo). Anti-CD19-PE or -PECy7 (1D3), anti-B220-PE or -
FITC (RA3-6B2), anti-c-kit-APC (2B8), anti-CD11b-PE (M1/70), anti-CD23-PE 
(B3B4), anti-CD4-PECy7 (GK1.5), anti-TCR-PE (H57), anti-CD18-PE (C71/16) and 
APC conjugated streptavidin were purchased from BD Biosciences. Anti-Gr-1-Biotin 
(RB6-8C5) was purchased from PharMingen. PE-conjugated streptavidin was 
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purchased from Southern Biotech. Anti-CD43-PECy7 (1B11), anti-CD11b -Pacific 
Blue (M1/70) and anti-Gr-1-APC (RB6-8C5) were purchased from Biolegend. Anti-
IgM-APC (M41), anti-CD19-APC (1D3), anti-CD93-Biotin (PB493), anti-CD21-APC 
(7G6), anti-CD8-APC (53-6.7), anti-CD45.1-FITC (A20) and anti-CD45.2-APC 
(104.2.1) were produced and labeled in laboratory of Prof. A. Rolink according to 
standard techniques. 
Statistical analysis 
The results are presented as mean ± SEM. Unpaired t test was used for the 
comparisons between two groups. *: p< 0.05; **: p <0.01; ***: p <0.001.  
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